Annual Report 2004 - UICCold.uicc.org/templates/uicc/pdf/ar/04.pdf · Arun P. Kurkure (India)...

Annual Report 2004International Union Against Cancer (UICC)

Union Internationale Contre le Cancer

Executive Commitee President: John R. Seffrin (USA) Chair of the Finance Committee: John C. Baity (USA) Past President:Eliezer Robinson (Israel) Treasurer: Louis J. Denis (Belgium) Members elected by the Council: Mary Gospodarowicz (Canada) Arun P. Kurkure (India) President-electFranco Cavalli (Switzerland)

Strategic LeadersRobert Burton (Australia) Kenneth Nilsson (Sweden) Yussuf Saloojee (South Africa) Hélène Sancho-Garnier (France)

MembersGraeme Brien (Australia) Michael Daube (Australia) Ketayun A. Dinshaw (India)Liisa Elovainio (Finland)

Tom Hudson (Ireland) Tomoyuki Kitagawa (Japan) Ray Lenhard (USA) Antonio Llombart-Bosch (Spain)Melissa S. Luwia (Indonesia) Claire Mallinson (UK) Ivano Humbert Marchesi (Brazil) H. Fred Mickelson (USA) Sherif Omar (Egypt)Thierry Philip (France) Robert Schweitzer (USA)Odd Søreide (Norway) Kazuo Tajima (Japan) Walter Weber (Switzerland) Susie Wilkinson (UK) David M. Zacks (USA) David Zaridze (Russia) You Hui Zhang (China) Miri Ziv (Israel)

Editor, International Journal ofCancerHarald zur Hausen (Germany)

Executive DirectorIsabel Mortara (Switzerland)

UICC has made every effort to ensure all information contained in this Annual Report is accurate and cannot be heldresponsible for any inadvertent errors that may have occurred.

Executive DirectorIsabel Mortara

Deputy Executive DirectorBrita Baker

AdministratorEvelyn Zuberbühler

Prevention and Early DetectionMaria Stella de SabataKatarzyna Stocka

Tobacco ControlSinéad Jones

GLOBALinkRuben IsraelHarold Colomes

Knowledge TransferBrita BakerSabine ArrobbioLohes RajeswaranKaren SilvermanRaluca GrigorescuAnouk Vittori

Patient Services/Relay For LifeAna OliveraLohes Rajeswaran

Finance and AdministrationRobert DuboisItalo GoyzuetaAnnie ImhofJeannette NyandwiPhilomène TaylorAnouk Vittori

Campaigns and CommunicationsJose Julio DivinoCarlos OcampoJérôme PitaultPáraic RéamonnAnna-Maria Vandelli

MembershipMargaret WalkerAnnie Imhoff

ACS LiaisonNancy Lins

The UICC staff wish to honour thememory of Mme Delphine Langer,their long-serving colleague, whodied in March 2005.

UICC Staff

UICC Council

Cover photo

Zoghrah is a teenage cancer survivor (see p.17). Millions more like her can survive if we act together now.

UIC

C A

nnua

l Rep

ort

2004

UICC Annual Report 2004 1

Table of contentsJoint message from the President and the Executive Director . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2UICC World Cancer Congress 2006 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3Milestones in 2004 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4Global cancer control . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5Saving lives by promoting health . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7Largest preventable cause of cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .10Research, technology and knowledge transfer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .12Cancer conferences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .15New frontiers in patient support . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .16Cancer '04: 4th World Conference for Cancer Organisations . . . . . . . . . . . . . . . . . . . . . . . . . . . .19UICC Awards . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .22UICC Conferences in 2005 and beyond . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .23UICC Member Organisations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .24Corporate Members . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .26UICC Roll of Honour . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .26Task Forces . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .27Fellows 2004 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .30Financial report . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .32

VisionUICC’s vision is of a

world where cancer iseliminated as a major life-threatening disease forfuture generations.

MissionUICC’s mission is to build and lead the global cancer control

community engaged in sharing and exchanging cancer con-trol knowledge and competence equitably, transferring scientificfindings to clinical settings, systematically reducing and eventu-ally eliminating disparities in prevention, early detection, treat-ment and care of cancers, and delivering the best possible careto all cancer patients.

2 UICC Annual Report 2004

Transforming knowledge into action

43% of cancer deaths worldwide are due to tobacco, diet and infec-tion. Global trends in cancer control can be significantly improvedthrough sustained strategies of primary prevention and early detection- particularly stopping tobacco use, encouraging healthy diets andphysical activity, and avoiding exposure to environmental hazards, UVradiation and infectious agents associated with certain cancers.

We know the importance of early detection and of prompt andappropriate treatment to reduce needless deaths.And we know thatscreening is possible for cervical, breast, colorectal, oral, prostate andstomach cancers.

What we need is to scale up cancer control initiatives, particularly incancer prevention and early detection, to build local treatment andresearch capacities within the context of local realities and resourcesettings and to ensure access to treatment as well as the availability ofpalliative care.

From resolution to implementation

UICC and its members advocate the adoption and implementationof the historic WHO Framework Convention for Tobacco Control.More people are expected to die from tobacco-related illness over thenext 30 years worldwide than the combined toll of AIDS, tuberculosis,road accidents, maternal mortality, homicide and suicide.

UICC also urges collaboration between NGOs and governments inimplementing the recommendations of the WHO Global Strategy onDiet, Physical Activity and Health. UICC and its members have a vitalrole in advocating implementation of the strategy through expert

advice and sharing of successfulevidence-based interventions.

Cancer should be a high priorityon WHO's agenda.Almost 11 mil-lion new cases of cancer arereported each year, more than halfof them in developing countries.By 2020, on current trends, therewill be 16 million new cancercases and over 10 million cancerdeaths each year.The CancerPrevention and ControlResolution recently adopted bythe World Health Assembly ofMinisters of Health from aroundthe world is a major achievement.UICC and its members can play asignificant role in ensuring theimplementation of this resolutionin every country, with tailoredstrategies to make effective use ofavailable resources.

UICC and its members wel-come continued collaborationwith WHO, its member countries,and non-governmental organisa-tions in bringing about tangibleresults through coordinated effortsin tobacco control and nationalcancer control plans.

Adapting UICC to a changingenvironment

As a membership-based union,UICC reflects the demanding andconstantly emerging needs of theglobal cancer control community.Following a review of its gover-nance and an ExtraordinaryGeneral Assembly in 2004, a num-ber of landmark changes werevoted by the Assembly that willenable UICC to be more flexible

The time to act is nowJoint message from the President and the Executive Director

We have the capacity to have a major impact on cancer trends worldwide even in the absenceof major breakthroughs. Yet, to realise our vision of a world where cancer is eliminated as a

major life-threatening disease for future generations, we require political will and commitment, andconcerted action across all sectors.

Photo credit: John Kaplan

UIC

C A

nnua

l Rep

ort

2004


and respond more readily to thechanging environment.TheUICC World Cancer Congress,which will meet next inWashington, DC in July 2006, willmove to a two-year cycle.

We take this opportunity tothank UICC members, volun-teers, partners, advocates and staff,whose dedication constantlyinspires us. Only through combin-ing our efforts will we be able tomeet the challenges ahead. Onbehalf of the almost 25 millionpeople living with cancerthroughout the world, let us worktogether to control cancer, toshare what we know, to ensure thebest available treatment andcare for all, and to avoid need-less deaths.

The time to act is now.

Dr John R. Seffrin

UICC President

Isabel Mortara

UICC Executive Director

The UICC World Cancer Congress 2006 will bring together theworld's foremost cancer control leaders and practitioners.The

Congress will integrate the World Conference for CancerOrganisations and the CDC 2006 Cancer Partners Summit, bring-ing the whole cancer control community together in a single set-ting.

The Congress will begin each day with a plenary session explor-ing ways to bridge the gaps in medicine and treatment, patient sup-port, prevention and the economics of cancer, and the future of can-cer control.

Five programme tracks - on 1) cancer research, detection andtreatment, 2) public health, prevention and education, 3) cancer sup-portive care, 4) building capacity in cancer organisations and 5)tobacco and cancer - will provide options for participants fromeither developed or developing countries. General plenaries andselected track plenaries will be translated simultaneously into Frenchand Spanish.A limited number of concurrent sessions will be con-ducted in either French or Spanish.Attendees of the same languageaffinity will also have an opportunity to meet daily.

For the first time in history, the Congress will be linked to theWorld Conference on Tobacco OR Health (12-15 July), with acrossover day between the two meetings.This unprecedented back-to-back event will unite the cancer and tobacco control communi-ties in a global campaign against tobacco-related cancer, whichthreatens to kill half a billion people living today.

A special dis-count is availableto those whoregister for boththe UICC

Congress and the13th WorldConference onTobacco ORHealth.

Visit the combinedconference website

at www.2006confer-

ences.org for furthernews and information.

UICC World CancerCongress 2006Bridging the Gap: Transforming Knowledge intoAction, Washington DC, 8-12 July 2006


Milestones in 2004

Throughout 2004 UICC, with its members and partners, built on the solid foundations laid in pre-vious years, strengthening its four strategic directions, advancing campaigns to put cancer con-

trol on the agenda everywhere, collaborating with other cancer control institutions and holding ahighly successful World Conference for Cancer Organisations in Ireland.

National cancer prevention and control planning

UICC worked closely with the World Health Organization(WHO), providing a civil-society perspective on the work WHO car-ries out with governments.

In May 2004, the Executive Board of WHO recommended the firstdedicated resolution on the prevention and control of cancer foradoption by the 58th World Health Assembly in 2005.

Cancer prevention and early detection

UICC hailed the adoption of the WHO Global Strategy on Diet,Physical Activity and Health at the World Health Assembly in May2004.

Evidence-based Cancer Prevention: Strategies for NGOs,A UICC

Handbook for Europe was officially launched at the UICC WorldConference for Cancer Organisations in Dublin.

Tobacco control

In March 2004, Ireland became the first country to impose anational smoking ban covering all workplaces, including pubs, restau-rants and bars.

In November 2004, Peru was the 40th nation to ratify theFramework Convention on Tobacco Control (FCTC), the world'sfirst-ever public health treaty, the treaty thus entering into force 90days later. UICC actively supported ratification and implementationof the treaty through FCTC implementation grants.

Research, technology andknowledge transfer

In 2004, UICC awarded almost200 International CancerFellowships, with US$ 880,000committed in funding. Over 4,000scientists and medical professionalshave now benefited from the fel-lowships programme.

Prof Aharon Ciechanover andProf Avram Hershko, two of thethree 2004 Nobel Laureates inChemistry, are former UICCFellows.

Work on UICC's flagship TNMclassification was strengthened bysetting up new national commit-tees in Brazil, Poland, Singaporeand Spain and by planning a newedition of Prognostic Factors in

Cancer.

Patient support

UICC launched a partnershipwith the International CancerInformation Service Group(ICISG) to promote the provisionof cancer information by UICCmembers through helplines andother forms of patient informationsupport.

In 2004, the Reach to RecoveryInternational network for breastcancer survivors included 84groups in 50 countries, with newgroups formed in Bangladesh,Ghana, Pakistan,Taiwan andThailand. Over 4,500 breast can-cer support volunteers have beentrained.There are regular confer-ences and a new biannualnewsletter, bloom.

UICC President, Council and Executive Director, Dublin, November 2004

UICC drafted two sets of guide-lines for setting up patient forums(to voice concerns and foster dia-logue among stakeholders) andHope Lodges (housing for patientsand families - "homes away fromhome"), both for release in 2005,with accompanying demonstrationprojects.

World Conference for CancerOrganisations

The 4th World Conference forCancer Organisations, held inDublin in November 2004, wasone of UICC's most successfulconferences.

Governance changes

Following an ExtraordinaryGeneral Assembly, held inNovember 2004, UICC will havea two-tier governance structurecomprising the General Assemblyand a Board of Directors (whichreplaces the existing ExecutiveCommittee and Council) account-able to the General Assembly,which will meet every two years.

The one-country-one-vote sys-tem currently in place will bereplaced by a one-organisation-one-vote system.As of July 2006,UICC membership will beextended to include individualmembers via common interestgroups appointed by the Board ofDirectors and focused on particu-lar areas of UICC work.

Dr Franco Cavalli, votedPresident-elect of UICC, will takeover the role of President in July2006.

UIC

C A

nnua

l Rep

ort

2004


Global cancer control

"Although cancer is a public health issue, it is given very littleattention in developing countries, including South Africa. Majorportions of health-care budgets in these countries are dedicated tothe control of communicable diseases such as HIV/AIDS, tubercu-losis, or malaria, leaving small portions for allocation to non-com-municable diseases such as cancer.

"I am proud to be part of the UICC family and believe thatthrough your encouragement we will improve the quality of lifefor people in rural communities in South Africa. First and foremost,the most important problem that we need to attend to is funding.UICC can help us to make cancer a priority in South Africa."

Ntuthu Somdyala, Medical Research Council, Cape Town, SouthAfrica

Challenges to cancer control

The reasons for the increase in cancer incidence and mortalityvary from region to region, but they include increased exposure torisk factors such as tobacco use, unhealthy diet, reduced physicalactivity, infections, and longer life expectancy.

A worldwide problem

One in eight deaths worldwide is due to cancer, whichclaims twice as many lives as AIDS. Often cancer is

regarded as a disease of the developed world, but withimproved living standards and longer life expectancy, cancerincidence in lower-income countries is on the rise. Cancer isthe second leading cause of death in developed countries,and epidemiological evidence shows that this trend is goingin the same direction in less developed settings. By 2020,three out of every five new cancer cases will occur in thesecountries. Cancer is a worldwide public health problem.

Executive Committee members at work


Survival outcomes also vary dramatically throughout the world - notjust between countries, not just between cities, but even between hospi-tals within the same city. Late diagnosis and wide variations in timelyaccess to quality cancer care are major causes of these discrepancies.

Planning for cancer control

Throughout 2004, UICC worked with WHO and other internationaland national partners to promote national cancer control planningefforts. Planning for cancer control is a good example of how cancerorganisations can work with national governments to advance the cancercontrol agenda. National cancer control plans provide a framework for allaspects of cancer control and promote the efficient use of availableresources in prevention, early detection and diagnosis, research, treatmentand palliative care.Their implementation involves priority setting, edu-cating and training health professionals, creating public awareness, tailor-ing screening and treatment to available resources, changing policies and

legislation, and coordinating infor-mation and communication servic-es.

UICC supports the develop-ment of prevention and earlydetection strategies in local set-tings and aims to improve accessto quality care for everyone livingwith cancer. Both globally,through its partners and volunteerexperts, as well as locally, throughits member organisations andgrassroots networks, UICC is wellplaced to disseminate knowledgeand foster best practices.

Cancer registration

UICC works with cancer regis-tration organisations such as theGroupe des registres de languelatine (GRELL) and the MiddleEastern Cancer Consortium(MECC) and is exploring the pos-sibility of joint activities with theInternational Association ofCancer Registries (IACR).

Developing software forSpanish-speaking hospital registrars

Cancer registration is the cor-nerstone of cancer control. Lack ofreliable data on a country's cancerburden is a serious barrier tonational cancer control planning.Hospital registries are a first stepin collecting this information.Commercial cancer registrationsoftware is often too expensive forcancer registries in lower-incomecountries and often not availablein languages other than English.Abstract Plus is an abstracting toolfor cancer registries developed bythe Centers for Disease Controland Prevention (CDC) in Atlanta,USA. It is used to summarise amedical record into an electronicreport of cancer diagnosis andtreatment. UICC partnered withCDC and the InternationalAgency for Research on Cancer(IARC) to translate this softwareinto Spanish and adapt it to theneeds of countries in LatinAmerica. Data fields, codes, recordlayout and edits are based on the

Cancer control in the Netherlands

The Dutch Cancer Society and the Dutch Association ofComprehensive Cancer Centres, both UICC members, are workingwith the Ministry of Health, Welfare and Sport, the DutchFederation of Cancer Patients' Organisation and the DutchAssociation of Health and Social-Care Insurance Companies on ajoint cancer control programme.

"The National Cancer Control Programme is intended to serve asa call to action to all organisations involved to achieve a number ofvital cancer control objectives in the next few years…The pro-gramme is anything but a one-off event. It is the start of a continu-ous process of collaboration aimed at improvement, quality control,and assessment of cancer in the Netherlands."

From the Dutch National Cancer Control Programme 2005-2010

Cancer control in Serbia

Since 2002, the Serbian health-care system has been in a processof reform and this has impacted upon cancer prevention, detectionand care. Today, Serbia still lacks a comprehensive cancer controlprogramme, but it is hoped that a national strategy and an actionplan for prevention and early detection will be drafted by the endof 2005.

"Although the Serbian Society for the Fight Against Cancer wasestablished in 1927 - before UICC existed, in fact - we still have tofight to become a valued partner of our government. UICC couldhelp us by gathering together all the emerging countries from theregion so we can exchange experiences and ideas about what isworking. We all had the same health system before and now we all

face the same problems.

The first advocacy activity of ourSerbian cancer society was actually theFCTC signing campaign that was initiat-ed by UICC. We think we were success-ful with it, but without that first initia-tive from UICC, we probably wouldn'thave done it."

Dr Ana Jovicevic Bekic, Secretary, SerbianSociety for the Fight Against Cancer

North American Association ofCentral Cancer Registries' stan-dards, which incorporate those ofthe American College of Surgeonsand the National Cancer Institute.The software is compatible withIARC's population-based softwareCanReg.The software has beenfinalised and pilot-tested and isbeing customised to respond tothe requirements of individualLatin American countries.

During two online sessions in2004, some 50 Latin Americanregistrars from 14 institutions in 9countries were trained in the useof Abstract Plus.Additional ses-sions in 2005 will ensure thatthere is at least one trained regis-trar in this software in every LatinAmerican country, following the"train-the-trainer" model.

UICC and its partners hope thatthis new cancer registration toolwill make it easier for hospitals inLatin America to collect cancerdata in a standardised form, as afirst step towards population-basedregistration.

UIC

C A

nnua

l Rep

ort

2004


Almost three million cancer deaths (43%) annually are due totobacco, diet and infection

Preventing cancer in Europe

Evidence-based Cancer Prevention: Strategies for NGOs is a UICC hand-book designed to help cancer societies, local and national healthauthorities and health professionals to capitalise on the wealth of solidscientific evidence available as they devise programmes to respondeffectively to cancer in their own countries.

Saving lives by promoting health

Prof Hélène Sancho-Garnier, Dr Andreas Biedermann, Dr Karen Slama and ProfAnnie Anderson of the Editorial Working Group

"The non-governmental organ-isations have to be involved,committed, and participate - andeven lead this movement. Thishas to be complemented by thegovernment and internationalorganisations like WHO. None ofthese entitities can do it alone."

Dr LEE Jong-wook, Director-General,

World Health Organization

Prevention and early detection

Global trends in cancer control can be significantlyimproved through sustained strategies of primary preven-

tion and early detection. By applying existing evidence-basedknowledge, it is possible to prevent at least one-third of thealmost 11 million cases of cancer that occur each yearthroughout the world. A further one-third can be treated suc-cessfully if detected early. In low- and middle-income coun-tries, 80% to 90% of cancer patients already suffer fromadvanced and incurable cancers at the time of diagnosis.Screening and early detection lead to decreased incidence andmortality, but only if effective treatment is readily accessible.

Source: IARC, 2000


The European edition of Evidence-based Cancer Prevention waslaunched at the UICC World Conference for Cancer Organisations inDublin in November 2004. It includes chapters on risk factors such astobacco, diet, alcohol, environmental hazards, UV radiation and infec-tious agents known to cause cancer, as well as effective actions toreduce population exposure to such factors, and recommendations thatNGOs can use as a template for developing their own strategies.

The handbook is available in English, French and Italian both online(www.uicc.org) and in print.A German edition and a summary inSpanish will follow.Workshops to facilitate the use of the handbookwere held during the Dublin conference. Further workshops will beoffered in partnership with member organisations during 2005.

Because the cancer burden, the pattern of risk factors and culturalelements are not the same everywhere,Asian and Latin American ver-sions of the handbook are being developed for publication in 2006.

UICC thanks the Swiss, French and Italian cancer leagues, theValencia chapter of the Spanish Association Against Cancer and theCredit Suisse Group Jubilee Foundation for their support in develop-ing this handbook.

Preventing cancer in the Asia-Pacific region

A UICCworkshop onPreventionand EarlyDetection ofCancer in Asiatargeted atsenior stafffrom UICCcancer soci-eties and min-istries of

health in Asia-Pacific countriestook place in Mumbai, India, inAugust 2004. It was organised incollaboration with the IndianCancer Society,Tata MemorialHospital, and the Asian PacificOrganisation for CancerPrevention (APOCP).

Its aims were to

focus on the prevention of can-cers caused by infection andthe major risk factors for non-communicable diseases, earlydetection, and screening fororal, stomach, cervical andbreast cancers,

"The international approach that was followed in developing thishandbook brought together experts from various countries with a

range of specialist knowledge andled to interesting new findings.Today, these findings are alreadyincorporated into discussions inSwitzerland, within the frameworkof formulating a national policy oncombating cancer."

Dr Franco Cavalli,Swiss Cancer League, andUICC President-elect

Tata Memorial Centre's urban outreach programme involves150,000 women in cancer education and screening.

"I have received the UICC manual Evidence-based CancerPrevention: Strategies for NGOs. I wish to express my appreciation forthe efforts of UICC staff and volunteers in writing and publishing thismanual, which is both highly scientific and practical."

Dr Davide Brunetti, Epidemiologist, Cancer Registry, Friuli-VeneziaGiulia, Trieste, Italy

"Education is the most effec-tive platform on which to fightcancer in the developing world:it is low-cost, low-tech, able toreach large populations quick-ly, and effective in motivatingpatients to seek early detectionand comply with treatmentregimes. This requires a changefrom active intervention toactive motivation and self-empowerment, particularly ofthose groups most at risk."

Dr Arun Kurkure, HonorarySecretary and ManagingTrustee, Indian Cancer Society

"Major difficulties with pri-mary preventive efforts aregetting across the message tothe target population in a con-vincing fashion and encourag-ing people to make lifestylechanges that are conducive toa healthier existence. We needto enlarge the section of socie-ty involved in policy debate.Our governments need tomake essential choices for ahealthy future, ensuring this isnot compromised by massivemedical burdens, either interms of finance or humansuffering. We should all beable to have our say."Dr Kazuo Tajima, Aichi CancerCentre, Nagoya, Japan

UIC

C A

nnua

l Rep

ort

2004


examine the Indian randomisedand other controlled-trial dataon low-technology screeningand its applicability to otherAsia-Pacific countries, and

establish a network for thedevelopment of Asia-Pacificeditions of the preventionhandbook.

Screening and early detectionof cervical cancer

Each year, almost half a millionnew cases of cervical cancer arediagnosed worldwide. More thanfour out of five cases occur in low-and middle-income countries,where cervical cancer is a leadingcause of death among women.Screening programmes can reduceboth incidence and mortality.UICC advocates cervical cancerscreening and assists programmesrequesting assistance with method-ology design.

In December 2003, a five-yearUICC pilot project in four LatinAmerican countries - theDominican Republic, El Salvador,Guatemala and Honduras - cameto an end. In 2004, an independ-ent audit commissioned by UICCreported favourably on the pilotproject and recommended follow-up actions.

UICC is grateful to theNorwegian Cancer Society for itssupport of the initial five-year pro-gramme. UICC is pleased that as aresult of the project, the Ministryof Health in El Salvador has set upa national cervical cancer controlplan and in Tegucigalpa, Honduras,a hospital cancer registry has beenexpanded into a population-basedregistry. UICC encourages thesharing of lessons learned withother countries embarking onsimilar projects.

Promoting healthy lifestyles

During the 2004 World HealthAssembly, UICC delivered a state-ment in support of the WHOGlobal Strategy on Diet, Physical

Activity and Health. UICC fullyendorses the global strategy andhailed its adoption.

Cancer and other non-commu-nicable diseases, including cardio-vascular disease, diabetes and obe-sity-related conditions, nowaccount for 60% of deaths world-wide and almost 50% of the glob-al burden of disease. In industri-alised countries, an estimated 30%of cancers are attributed to anunhealthy diet and a sedentarylifestyle - almost as many as totobacco use.

The Global Strategy offers arange of policy options to addressthese two risk factors. It emphasis-es the need for countries to devel-

op national strategies, with specific roles for governments, civil societyand the private sector.

It calls on the food industry toadopt clear and consistent food-labelling practices and evidence-based health claims to help consumers make informed choices,

limit the levels of saturated fats, trans-fatty acids, sugar and salt inits products, and

follow responsible marketing practices, particularly in promotingfoods high in saturated fats, sugar or salt, especially with regard tochildren.

Unlike the Framework Convention on Tobacco Control (FCTC),the policies proposed are non-binding and non-prescriptive, leavingresponsibility for action in the hands of governments. UICC will assistits members in advocating the strategy through expert advice and thesharing of best practices, in cooperation with the World HeartFederation and other partners.

"The best examples ofoverall dietary change comefrom the Nordic countries.These serve to remind usthat promoting dietarychange is due not just toeffective health educationprogrammes and individualaction but also to communi-ty participation, industryinvolvement and nationalpolicy frameworks withimplementation and moni-toring strategies."

Prof Annie Anderson, Centre for Public Health

Nutrition Research,University of Dundee,

Scotland


By 2030, if current trends continue, tobacco will kill more than 10million people each year, two-thirds of them in lower-income coun-tries.As the tobacco industry intensifies its targeting of these coun-tries, effective action is needed now to cut tobacco use and save lives.

The world's first publichealth treaty

The WHO FrameworkConvention on TobaccoControl (FCTC) marks acritical turning point inthe fight against tobacco.In November 2004, theglobal struggle againsttobacco-related diseaseand death passed a mile-stone when Peru becamethe 40th nation to ratify

the FCTC. In February 2005, it became international law.

In March 2004, UICC launched the FCTC Now! campaign,together with the International Non-Governmental Coalition AgainstTobacco (INGCAT) and the Framework Convention Alliance (FCA),urging governments to sign and ratify the treaty.

In June 2004, the UICC delegation to the WHO IntergovernmentalWorking Group lobbied, held a briefing session for delegates and con-tributed to the formal discussions.Together with the FrameworkConvention Alliance, it conducted a workshop for African delegateson developing action plans for ratification of the FCTC.

The FCTC commits governments to enacting a minimum set ofpolicies that are proven to curb tobacco use, including comprehensivebans on tobacco promotion, clear effective warning labels, smoke-free

policies, and increasing the priceof tobacco through taxation.Thetreaty also promotes internationalcooperation in dealing with ciga-rette smuggling and cross-borderadvertising.

UICC provides support forFCTC implementation by work-ing together with its partners todevelop and strengthen advocacyskills, particularly in lower-incomecountries. FCTC ImplementationGrants, funded by the AmericanCancer Society and CancerResearch UK, have been made insupport of 12 projects inArgentina, Bangladesh, the CzechRepublic, Georgia, India, Malawi,Nepal, Nigeria, Pakistan, SouthKorea, Uganda and Uruguay.

Largest preventable cause of cancerTobacco use is one of the largest preventable causes of disease and premature death in the world.

Each year, tobacco kills around 5 million people, of whom 1.2 million die of lung cancer. Halvingtobacco consumption now would save at least 170 million lives by 2050.

"Even in the face of the above figures, tobacco companies continueto say that their marketing and advertising are not designed to appealto children. The paradox at the heart of the tobacco trade is that whiletobacco companies are not permitted to encourage children to smoke,their very survival depends on recruiting new young smokers, so theycontinue to find ways around this. Between 1965 and 2003, thetobacco industry recruited 1.9 million young smokers in Australia,who smoked an estimated 263 packs per year - or 9.7 billion packsacross 38 years."

Prof Simon Chapman, Professor of Public Health,University of Sydney, Australia

"Tobacco has created a glob-al health emergency. One per-son dies every 30 seconds dueto cancer caused by smoking,yet more people are smokingthan at any other time inhuman history. The steps forcontrolling tobacco use in anycountry are really very simple:increase the price of cigarettesby raising taxes, ban the glam-orisation of the product by ban-ning tobacco advertising, spon-sorships and promotion, andprotect the health and rights ofnon-smokers by making publicplaces smoke-free. By takingthese simple steps, govern-ments can considerably reducetobacco use in their popula-tions very quickly."

Dr Yussuf Saloojee, UICCStrategic Leader, TobaccoControl

UIC

C A

nnua

l Rep

ort

2004


Towards a tobacco-freePakistan

The first step by the PakistanAnti-Tobacco Coalition was todeepen its regional coordinators'understanding of the need forPakistan to sign and ratify theFCTC.This was followed by a let-ter-writing campaign urging theMinister of Health to sign it, andregular contact with journalists,which resulted in 27 FCTC-relat-ed articles in the press and tworadio programmes.World NoTobacco Day 2004 was marked byseminars in different parts ofPakistan.

The coalition also worked withthe non-governmental organisa-tion Heartfile in developing anational action plan to controlnon-communicable diseases. Itwrote the tobacco control section,in which all 11 FCTC articles areaddressed.The plan, accepted bythe government and publiclylaunched in May 2004, is the firstexample of this kind of partner-ship between government andNGOs in Pakistan.

Pakistan signed the FCTC in May2004 and ratified it in November2004.Tobacco control is now a pri-ority for the government.

Empowering tobacco control professionals

UICC’s GLOBALink (www.globalink.org) is the home of the globaltobacco control community, uniting advocates, policymakers,researchers, educators, doctors, economists and lawyers. GLOBALinkalso serves local, regional and other specialised tobacco control groups.

In support of World No Tobacco Day 2004, UICC launchedGLOBALink Radio and provided links to audio interviews with theworld's leading tobacco control professionals.

May 2004 saw the launch of GLOBALink language-specific net-works in Arabic, Portuguese and Russian.

In September 2004, GLOBALink was present with a Cybercentre atthe 7th Asia-Pacific Conference on Tobacco or Health in Gyeongju,Republic of Korea.Ten computers were at the disposal of attendees,and during the closing ceremony GLOBALink presented laptop com-puters to five tobacco control professionals, which will be used toadvance tobacco control in the Asia-Pacific region.

GLOBALink now hosts 132 LOCALinks.This includes the entireinternet infrastructure of the FCA; INGCAT; the French Comiténational contre le tabagisme (CNCT); the Alcohol and DrugInformation Centre,ADIC-Ukraine; and the Observatoire du tabac enAfrique francophone (OTAF). Recent additions include the GlobalTobacco Research Network and the Swiss Tobacco Action Network.

Judy Wilkenfeld (Campaign for Tobacco-Free Kids), Dr Yussuf Saloojee, andProf David Simpson (International Agency on Tobacco and Health)

"To make tobacco control apriority in a developing countryrequires every bit of financialand technical assistance avail-able, as economic issues are atthe top of the political agenda.For us, the FCTC advocacygrant provided both the finan-cial and technical help weneeded. With this grant, wewere able to successfully con-vince policy makers of theimportance of the FCTCprocess, through generating ademand from the people affect-ed by it."

Dr Ehsan Latif, NationalCoordinator, Pakistan Anti-Tobacco Coalition The John Tung Foundation, Taiwan, a new UICC member, supported the Quit

& Win 2004 anti-smoking campaign.


IIrreellaanndd ggooeess ssmmookkee--ffrreeee

In March 2004, Irelandbecame the first country in theworld to introduce a nation-wide ban on smoking in theworkplace. From that date, ithas been illegal to smoke in allpubs, restaurants and otherworkplaces. The push towardsa smoke-free Ireland began in1994 with a ban on smoking inall public places. A voluntaryworkplace code was intro-duced, an important steppingstone to the total ban. Aroundthe same time, the Irish CancerSociety began to lobby minis-ters on environmental tobaccosmoke (passive smoking).

In 2003, a scientific expertreport by the Office of TobaccoControl concluded that envi-ronmental tobacco smoke wasa significant carcinogen fromwhich all workers should beprotected. Against considerableopposition from powerful lobbygroups and vested businessinterests, the then Irish HealthMinister Micheál Martinpushed through a full ban onworkplace smoking. Surveysshow a 97% compliance rate,sales of cigarettes have fallen,and public support for themeasure continues to grow.

In December 2004, work-places in New Zealand alsobecame smoke-free. Othercountries have since followedIreland's example. Australia,Bhutan, Iran, Malta,Montenegro, Norway, Tanzania,Turkey, Uganda, and parts ofCanada, the UK and the UnitedStates have all imposed banson smoking in bars, clubs andrestaurants. In November 2004,Bhutan announced a nationalban on the sale of all tobaccoproducts.

UICC aims to transfer knowledge, skills and expertise to wherethey are needed, through fellowships and training, building interna-tional networks of cancer experts, promoting global use of the uni-fied TNM classification, and providing a forum for learning and dia-logue through international cancer conferences.

UICC International Cancer Fellowships

In 2004, 195 new Fellows joined over 4,000 scientists and medicalprofessionals who had benefited from the UICC fellowships pro-gramme in the past.The breakdown is as follows:

The fellowships programme offers continued professional develop-ment to a comprehensive range of health professionals: behavioural

Research, technology andknowledge transfer

Despite an unprecedented understanding of cancer andphenomenal advances in biotechnology, the gap

between what is scientifically known and what is practicallyapplied is widening. In developed countries, the estimated5-year survival rate of patients with cancer is 50%-60%,but the world average is only 30%-40%. Significant dispar-ities exist between countries in terms of access to qualityinformation, prevention, screening, treatment and support-ive care.

UICC Translational Cancer Research Fellowships . . . . . . . . . . . . 1UICC American Cancer SocietyInternational Fellowships for Beginning Investigators . . . . . . . . 8UICC Yamagiwa-Yoshida Memorial International Cancer Study Grants . . . . . . . . . . . . . . . . . . . . . . . 12UICC International Cancer ResearchTechnology Transfer Fellowships . . . . . . . . . . . . . . . . . . . . . . . .151UICC Trish Greene International Oncology Nursing Fellowships 11UICC Asia-Pacific Cancer Society Training Grants . . . . . . . . . . . 12Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .195

"One of the very importantopportunities for us is to deliverinto the community many of thenew advances that have beenmade in cancer research and ther-apy. Working with non-govern-mental organisations, we can real-ly touch people where they live."

Dr Andrew von Eschenbach,National Cancer Institute, USA

scientists, clinicians, epidemiologists, general practitioners, investiga-tors, laboratory technicians, nurses, cancer society staff and volunteers,and public health and tobacco control educators.The fellowships arefunded by special contracts, grants or contributions from UICCmember organisations as well as governmental agencies and commer-cial sponsors.

In 2004, the Association of UICC Fellows increased its membershipto over 1,000 Fellows in 93 countries.

The network of over 500 volunteer fellowship reviewers is contin-uously updated to ensure that all research and clinical disciplines areadequately covered.These experts review between 1,000 and 1,200applications each year.

International cancer technology transfer

Almost three-quarters of the fellowships awarded in 2004 assistedqualified cancer professionals, generally in the early stages of theircareers, with rapid acquisition of specific skills in cancer prevention,diagnosis, research or treatment.After financial constraints in 2003,funding for these International Cancer Research Technology Transfer(ICRETT) fellowships climbed back to nearly US$ 500,000, thanksto fresh or increased support from the American Society of ClinicalOncology and the National Cancer Institute, USA.

A one-year follow-up evaluation of almost 200 ICRETT Fellowsfrom all regions showed that they acquired 471 new skills and passedthem on to over 3,200 of their colleagues, making this a highly cost-effective way to spread cancer knowledge.

Cooperation expands brachytherapy in Peru

In 2004, UICC launched Reverse ICRETT Fellowships, a schemeto support research and clinical management training in low-incomecountries.

Dr Subir Nag and Dr NinaSamsami from Ohio StateUniversity Hospital, Columbus,and Dr Luis Pinillos Ashton of theNational Cancer Institute, Peru,led a five-day brachytherapy train-ing workshop for over 70 healthprofessionals from Peru andBolivia.With Reverse ICRETTfunding for the travel and accom-modation of the international fac-ulty, the course provided 25 hoursof theory and 15 hours in thebrachytherapy suite of theNational Cancer Institute.Participants included 21 radiother-apists, 22 physicists, 25 medicaltechnologists and 8 nurses.

Cancer society training in theAsia-Pacific region changescourse

The profile of UICC's Asia-Pacific Cancer Society TrainingGrants changed radically in 2004,following an evaluation of thisscheme for cancer society staff andvolunteers. It now offers a choiceof participating in eight trainingand development campaigns - incancer/tobacco control, advocacy,cancer helpdesk, clinical trials, andsupportive care - run by cancersocieties in Australia, India andSingapore.

Cancer classification - TNMand prognostic factors

Appropriate treatment of cancerpatients is impossible without

Brachytherapy training at the National Cancer Institute, Lima, Peru

"Under the UICC fellowships pro-gramme, people from all over theworld visit other cancer prevention,research, treatment and care centres,sharing their knowledge as well asgathering new skills and information.Then they return home and spreadtheir new knowledge, empoweringthose around them in continuing can-cer control efforts."

Dr Kenneth Nilsson, UICC StrategicLeader, Knowledge Transfer

"Since the workshop, wehave improved the quality ofservice to our patients. We aredeveloping new areas forbrachytherapy treatment, suchas treating prostate and softtissue tumours. Up to now, wewere only treating cervical can-cer. We treat an average of fivebrachytherapy patients dailyand will probably increase thisby 50% due to the pre-treat-ment planning skills we havedeveloped."

Dr Luis Pinillos Ashton,National Cancer Institute, Peru

UIC

C A

nnua

l Rep

ort

2004



knowledge of the extent or stage of their cancer.The global stan-dard in cancer staging is the TNM classification - primary tumour(T), regional lymph nodes (N) and distant metastasis (M) - devel-oped by Pierre Denoix and adopted by UICC in 1953.

UICC updates and promotes the global use of the UICC TNMclassification to ensure uniform standards in the classification andstaging of cancer.The objectives are to aid the clinician in classifyingand staging the tumour in order to plan the treatment, give an indi-cation of prognosis, assist in the evaluation of the results of treat-ment and facilitate the exchange of information.

New national TNM committees are being set up in Argentina,Australia, Brazil, Hungary, India, Ireland, the Netherlands, Poland,Singapore and Spain. Once formally constituted, they will join thegroup of existing national committees in Canada, Germany, Italy,Japan, and the USA.Their chairs will form the Global TNMAdvisory Group to work closely with the TNM Core Group andthe Expert Panels in preparing the seventh edition of the TNM

Classification of Malignant Tumours, scheduled for publication in 2009.

Recognising excellenceUICC Fellows share Nobel Prize for Chemistry

The Royal Swedish Academy of Sciences awarded the 2004Nobel Prize for Chemistry for "the discovery of ubiquitin-mediatedprotein degradation" jointly to Prof Aharon Ciechanover and ProfAvram Hershko of the Technion-Israel Institute of Technology, Haifa,and Dr Irwin Rose of the University of California, Irvine, USA.

Two of the three are former UICC Fellows. Prof Ciechanoverreceived an ACS International Cancer Research Fellowship in 1988.Prof Hershko received an ACS International Cancer ResearchFellowship in 1996 and a Yamagiwa-Yoshida Memorial CancerStudy Grant in 2000.

At the beginning of the 1980s, these investigators discovered oneof the cell's most important cyclical processes: regulated proteindegradation.Thanks to their work, it is now possible to understandhow the cell controls a number of central processes by breakingdown certain proteins and not others.When the degradation doesnot work correctly, people become ill. Cervical cancer and cysticfibrosis are two examples.

Germany honours International Journal of Cancer editor

In April 2004, Dr Harald zur Hausen received the Order of Meritof the Federal Republic of Germany, one of the country's mostprestigious distinctions, in recognition of his achievements in cancerresearch.

The Order of Merit is a public recognition by the President of theFederal Republic of Dr zur Hausen's pioneering work in the field of

tumour virology, as well as hisachievements as President andScientific Director of theDeutsches Krebsforschungszentrumin Heidelberg, the German cancerresearch centre.

Dr zur Hausen is a member ofUICC's Council and since 1999 hasbeen Editor-in-Chief of UICC'sInternational Journal of Cancer.Since the 1970s, his research hasconcentrated on the human papillo-mavirus. He identified certain types

"The UICC TNM helpdesk (www.uicc.org/index.php?id=570) notonly answers staging questions for the management of individualpatients and the recording of their data, it serves to highlight areasin need of further clarification for future revisions of the TNM clas-sification."

Dr Leslie Sobin, Chief, Division of Gastrointestinal Pathology,Armed Forces Institute of Pathology, Washington, DC

"The Nobel Prize was pre-sented to us for our discoverythat has led and will continueto lead to the detection of var-ious cancer diseases' mecha-nisms and the development ofdrugs to fight them.

Some years ago, as a youngresearcher and physician, Ireceived assistance from theIsrael Cancer Association andUICC fellowships, and Ilearned up close about the sig-nificant work that these associ-ations do to promote research,prevention and early detection,and improve treatment condi-tions for patients. It was thenthat I realised that research isinextricably linked to under-standing the disease and ispotentially life-saving."

Prof Aharon Ciechanover, 2004 Nobel Laureate in Chemistry and former UICC Fellow

UIC

C A

nnua

l Rep

ort

2004


of the papillomavirus to be a causeof cervical cancer, the third cause ofmortality in women. On the basisof these results, there is a worldwideeffort to develop a vaccine to pro-tect from papilloma-type virusesand consequently prevent cervicalcancer.

Training

Together with the UICCInternational Cancer Foundation,UICC held a leukaemia courseand forum in Moscow in April2004 for Russian haematologists,pathologists and oncologists.Participants analysed ways toimprove diagnosis and treatmentof leukaemia in Russia. Open lec-tures were given by European andUS experts, and Russian researchwas presented.

An interactive UICC e-learningtool on cancer basics is in prepara-tion, based, by kind permission ofthe Oncology Nursing Society, ontheir Cancer Basics course. It is tai-lored to the cancer knowledgeneeds of general practitioners,nurses and allied health profession-als who care for cancer patients inlow- and middle-income coun-tries. Pilot versions are beingdeveloped for testing in 2005 bycollaborating nursing schools andhospitals in India, Panama, Poland,Singapore and South Africa.

Conferences held under

Dr Harald zur Hausen

the auspices of UICC in 2004 included:

XI International Congress of Ocular Oncology,India (January)

2nd APOCP Regional Meeting, Thailand (February)

International Forum on Cancer, Algeria (March)

5th International Conference of the Adjuvant Therapyof Melanoma, Greece (March)

International Breast Cancer Screening NetworkCouncil, Norway (May)

International Skin Cancer Congress, Switzerland (July)

XI Peruvian Congress of Medical Oncology, Peru(August)

Asia-Pacific Conference of Tumour Biology andMedicine, 21st IATMO, China (August)

Prediction of Patient Outcome in Prostate Cancer:Prognostic Factors 2004, International Consultation,Sweden (September)

2nd International Conference, Cancer on the Internet,USA (September)

Moscow Breast Cancer Forum, Russia (September)

XI Biennial Conference of the Indian Society ofOncology & XII Biennial Conference of the IndianSociety of Medical & Paedriatric Oncology, India(October)

Oncology Nursing Society Institutes of Learning, USA(November)

International Conference of Society for IntegrativeOncology, USA (November)

9th Asia-Pacific Bone Marrow TransplantationCongress, Iran (November)

Cancer conferences

UICC's International Calendar of Cancer Conferenceslists major international cancer-related conferences,

meetings and congresses over three years and is available inprint and at www.uicc.org. In 2004, 16,000 copies of theprinted version were distributed, thanks to funding fromNovartis Oncology.


Empowering breast cancer patients and survivors

UICC's Reachto RecoveryInternational(RRI) is a net-work of breastcancer advocacy,education andpatient supportgroups.Withnew associatemembers inBangladesh,

Ghana, Pakistan,Taiwan and Thailand, the network now has 84 groupsin 50 countries.

In 2004, the RRI newsletter was redesigned and launched under itsnew name, bloom.The newsletter is for newly diagnosed breast cancerpatients and long-term survivors, as well as volunteers and coordina-tors of breast cancer support groups, nurses, general practitioners, andbreast cancer advocates.Two issues were published and are availableonline at www.uicc.org.

"Enriching Lives"

2nd UICC Asia-Pacific BreastCancer Support Conference,Singapore, 1-4 September2004

The conference, hosted by theSingapore Cancer Society andthe Singapore Breast CancerFoundation, brought together

350 survivors, volunteers, familymembers, doctors and health-careprofessionals. It emphasised theneed to address emerging issuessuch as advocacy and the growingnumber of younger women withbreast cancer.

Rosalind Lee of Singapore waspresented with the UICC 2004Reach to Recovery InternationalAsia-Pacific Volunteer Award inrecognition of her outstandingcommitment and contribution tothe Reach to Recovery pro-gramme in the Asia-Pacific region.Prof Yip Cheng Har of Malaysiareceived the first UICC Reach toRecovery International Asia-Pacific Health Professional Awardin recognition of her outstandingcommitment and contribution tobreast cancer support programmesin the region.

New frontiers in patient support

UICC's mission is to lead and enable the global community in delivering the best possible careand support to all people living with cancer. The role of patient organisations in advocacy and

support is increasingly important today. UICC works with and supports these groups and providestraining and a forum for their leaders at the World Conference for Cancer Organisations.

Blue Veins Breast Cancer Awareness March, Pakistan

Rosalind Lee receiving the Outstanding RRI Volunteer Award

"The next step in Reach to Recovery International is to ensurethat there is solidarity among women with breast cancer. We canthen unite to ask for our rights, because we can demand the type oftreatment we want, we can demand the type of jobs we should bedoing, and we can demand the kind of life we want to live."

Ranjit Kaur, President, Reach to Recovery International

Ranjit Kaur

UIC

C A

nnua

l Rep

ort

2004


Pink October 2004

Since 1998, October has been breast cancer awareness month.National cancer leagues and Reach to Recovery groups organisedinnovative fundraising events, breast cancer awareness campaigns, freemammography, breast examinations, television programmes, radio talksand marches, and wrote letters to their governments demanding rightsfor women living with breast cancer.

In Africa, events were organised by Reach to Recovery groups inGhana, Kenya, Nigeria and South Africa.Testimonies by survivors inGhana helped to reduce the fear and social stigma associated withbreast cancer.The Kenya Breast Health Programme called their cam-paign "Closer to Cure", emphasising the importance of early detec-tion. Under the title of "Enlisting grassroots participation in the fightagainst breast cancer", the Breast Cancer Association of Nigeria tookits rally to the Mokola market in Ibadan.

Reach to Recovery groups in Australia, Hong Kong, Japan, Malaysia,Singapore,Taiwan and other countries in the Asia-Pacific regionorganised a wide range of events, including breast self-examination asan educational programme in schools, dragon boat races, and a confer-ence for patients on Women's Fight Against Breast Cancer.

Pink October events were widespread in Europe too. Letters weresent to governments demanding better health services for women withbreast cancer, early detection messages were targeted at youngerwomen, awards were presented to professionals and volunteers for

their contributionto breast cancerawareness, andfundraising wasinnovative and verysuccessful.

Awareness cam-paigns took placeacross Argentina.Important buildingsin Buenos Aireswere lit up in pinkone day during themonth.The skycarried balloons

with messages of hope andemphasising the importance ofearly detection.

Patient forums: Giving a voiceto cancer patients worldwide

UICC actively promotes patientforums, which give a voice topeople living with cancer in orderto break down the barriers ofsilence and fear and initiate dia-logue between patients and themedical community.They alsokeep cancer in the public spot-light, raising public awareness andthus strengthening the prioritygiven to cancer control.

Guidelines and application formsfor seed grants and auspices willsoon be available online for UICCmembers.

Hope Lodges - homes awayfrom home

One barrier to cancer treatmentis distance from treatment centres.Patients do not stay long enoughto await diagnosis or to receiveproper care, because they cannotafford the cost of living away fromhome.To meet the needs ofpatients and families, Hope Lodgeshave been established, where peo-ple with cancer and their familiescan stay during treatment for freeor for a nominal fee.To assist itsmembers and other organisations

Dragon Boat World Championship, Italy

Queen Silvia of Sweden receives a pink ribbon fromEva Eriksson of the Swedish Breast CancerOrganisation (BRO).

Zoghrah, a teenage cancer survivor,spoke at a community event in Delft,Western Cape, South Africa, to mark

World Cancer Day


in starting such lodges, UICC is drafting a practical guide to be madeavailable online in 2005. It will present three examples of HopeLodges in developed, middle-income and low-income countries andwill cover needs assessment, legal, architectural, human and financialissues, and practical information on how to run a lodge.

In 2004, UICC provided technical assistance to member organisa-tions in Turkey, where a Hope Lodge is being built, and to Algeria,where one is planned.

Improving patient information services

In 2004, UICC and the International Cancer Information ServiceGroup (ICISG) became partners in an effort to strengthen the deliv-ery of cancer information. One of the main goals is to assist UICCmember organisations to set up or expand their patient informationservices, including telephone helplines, in-person counselling, publica-tions and other educational materials, and newer electronic services byemail or on the web.

UICC and ICISG are working together in the development of ajointly branded online training manual for the development of cancerinformation services, to be launched at the 2006 World CancerCongress in Washington, DC.

The ICISG is an independent network of cancer information pro-grammes that was formed in 1996 to help cancer organisationsthroughout the world establish and deliver cancer information servic-es. It has over 40 member organisations in 28 countries.

A great year for Relay For Life

Relay For Life, launched internationally by the American CancerSociety (ACS) in partnership with UICC, is a unique overnight eventthat celebrates cancer patients and survivors.The event raises funds forcancer societies and brings communities together to support the fightagainst cancer through education, advocacy, research and patient serv-ices.

2004 markedthe 20thanniversary ofRelay For Life,with activitiesby UICC mem-bers in morethan 20 coun-tries.What start-ed as a singlecommunityevent organised

by ACS in 1985 has now expand-ed to more than 4,200 events incommunities around the worldand has become the world's largestcancer fundraising event.

Representatives from SouthAfrica attended a US-based train-ing session and are preparing tohold events in 2005. In Asia, thePhilippines and Taiwan celebratedtheir first events in 2004. Malaysiawill soon add its name to the listwith its first event planned forMarch 2005.

In Latin America, Guatemalaand Honduras held successfulevents. Mexico and Venezuelaattended training and plannedtheir first events for 2005.

Relay For Life was successfullylaunched in western Europe withgenerous support from sanofi-aven-tis.The first event in continentalEurope took place in Massa, Italy,in September 2004, followed by asecond in Rome in November.Belgium, Germany, Greece andPortugal plan events for 2005. InAustralia, 77 venues hosted RelayFor Life, raising over AU$ 6.5 mil-lion (about US$ 5 million).

Relay For Life, Honduras

"Cancer patients, survivors and their families are a formidableforce in the fight against cancer. They are demanding a strongervoice in policy, treatment and care and are actively striving to com-bat the social stigma still associated with cancer in many countries.One of our goals is to help them organise themselves so that theycan be heard, particularly in low- and middle-income countries."

Isabel Mortara, UICC Executive Director

Taiwan

In September 2004, Taiwansuccessfully celebrated its firstRelay For Life. The event, host-ed by the Formosa CancerFoundation, the Taiwan CancerSociety and the Hope Society,focused on celebrating survivor-ship, cancer education andadvocacy, as well as introducingfundraising and volunteerrecruitment concepts to civilsociety.

“A total of 73 teams wereformed and US$ 46,970 wasraised. Strikingly, 59 survivorstook part - an impressive figure,since cancer survivors in Taiwanprefer not to share their condi-tion.”

Dr Gi-Ming Lai, FormosaCancer Foundation

Opening the conference, the Irish Prime Minister,Mr Bertie Ahern TD, applauded his country's "land-mark effort to protect employees, children and oth-ers from the toxic effects of tobacco."

This was the fourth World Conference of CancerOrganisations, but for a number of developingnations it was a first.There was significant attendance

from low- and middle-income countries, includingCuba, Ghana, India, Jamaica, Jordan, Libya, Malaysia,Nigeria,Tunisia and Zimbabwe.These countries bearthe greater part of the world's cancer burden yet suf-fer a chronic lack of resources in cancer screening,public health education and access to treatment andpalliative care.

CANCER '04

UICC 4th World Conferencefor Cancer Organisations, Dublin, Ireland, 16-19 November 2004

The WCCO was one of UICC's most successful confer-ences, attracting more than 800 delegates from 82

countries. Expert speakers from all continents gave presen-tations, led symposia, and hosted workshops addressingevery aspect of cancer care: national cancer plans, latestmedical and scientific advances, patient-care initiatives,strategies to combat aggressive new marketing by thetobacco industry, and effective fundraising techniques.

UIC

C A

nnua

l Rep

ort

2004


This was the fourth WorldConference for Cancer Organisations,but for a number of developingnations it was a first.There was signif-icant attendance from low-incomeand middle-income countries, includ-ing Brazil, Colombia, Cuba, Egypt,Ghana, Guatemala, Honduras, India,

Indonesia, Iran, Jamaica, Jordan, Kenya, Libya, Moldova, Nepal, Niger,Nigeria, Pakistan, the Philippines,Tanzania,Tunisia,Turkey, andZimbabwe.These countries bear the greater part of the world's cancerburden yet suffer a chronic lack of resources in cancer screening, pub-lic health education and access to treatment and palliative care.

Opening the conference, the Irish Prime Minister, Bertie AhernTD, applauded his counry's "landmark effort to protect employees,children and others from the toxic effects of tobacco."


Dr Peter Boyle, Director of the International Agency for Research onCancer (IARC) in Lyon, France, spoke about national priorities in can-cer control. Since the launch of the Europe Against Cancer initiative in1985, primary prevention, tobacco control, screening, education andtraining has led to a reduction in mortality of 9% across the European

Union, he noted.This correspondsto 92,500 fewer cancer deaths - asubstantial achievement against abackground of increasing inci-dence linked largely to Europe'sageing population.

Dr Andrew von Eschenbach,Director of the National CancerInstitute, USA, told delegates thatwe now have a very good under-standing of the cancer process, andthe biomedical revolution ofrecent years has led to fundamen-tally new strategies in treatment.In the future, instead of treatingthe end stages of cancer, much ofour intervention will occur at thefront end of the disease processthrough prevention, detection andmodulation strategies.Advances ingenomics, proteomics, imaging,nanotechnology - all offer excep-tional opportunities to improvecancer care.We need to under-stand that the person, as well asthe tumour, needs to be treated,and that we need to improve ourunderstanding of cancer as itaffects populations, not just peo-ple.

Also new was a welcome focus on patient advocacy initiatives, such aspatient forums, that provide effective platforms for people living withcancer, caregivers and cancer survivors worldwide to voice their needsand concerns to the medical community and government.

Staff and volunteers of the Irish Cancer Society, the conference hosts


Dr Susanne Dalton, a researcher at the Danish Institute of CancerEpidemiology, presented an overview of research in psycho-oncology,underlining the potential to improve survival rates through differentkinds of psycho-social support.

The CEO of the Irish CancerSociety, Dr John McCormack,urged the global cancer controlcommunity to work togethermore closely and to use eventssuch as the UICC WorldConference for CancerOrganisations to strengtheninternational partnerships andnetworks that would help speedadvances in prevention, earlydetection, diagnosis, treatmentand patient care.

Highlights from the plenary ses-sions were published in a 12-pagebooklet, available in print andonline at http://www.uicc.org/filead-

min/user_uploadUICC/Main_Site/

News_Content/events/dub04hl.pdf.

The conference was hosted bythe Irish Cancer Society, withsanofi-aventis and AstraZenecaas gold sponsors.

"How is it that so many depressed cancer patients seem to goundiagnosed? Perhaps because distress is a normal reaction to acancer diagnosis, making it harder to detect actual clinical depres-sion. A recent study in Denmark showed a 50% increased risk ofclinical depression for those with cancer, even many years after theinitial diagnosis."

Dr Susanne Dalton,Danish Institute of Cancer Epidemiology

"The most important thingwe've learned from this confer-ence is that this doesn't have tobe the story - the story couldbe quite different - but wehave to do the right thing. Aswe leave this conference, weknow that we need to put can-cer on the public policy agendaall around the world. We knowthat every country needs todevelop a cancer plan. If you'renot planning, you're planningto fail."

Dr John R. Seffrin, UICC President

The closing ceremony

UIC

C A

nnua

l Rep

ort

2004


Outstanding government

official

Micheál Martin, the formerIrish Minister of Health andChildren, received the award forhis pivotal role in implementingthe workplace smoking ban inIreland in March 2004. In present-ing the award, UICC ExecutiveDirector Isabel Mortara pointed tohis unfailing commitment to theadoption of this ground-breakingpublic health legislation, whichhad been widely accepted inIreland and served as a model forother nations.

Outstanding UICC volunteers

Dr Leslie Sobin was presentedwith the award for his work asChair of the UICC TNMPrognostic Factors Project, a posthe has held since 1982. Dr Sobinhas been the driving force behinddisseminating TNM information,translating it into many languagesand developing its online poten-tial.

Ranjit Kaur from Malaysia is thePresident of Reach to RecoveryInternational. She is a breast can-cer survivor who has initiated out-standing advances in internationalbreast cancer awareness andpatient support. Ranjit Kaur wascited for her inspirational leader-ship in Reach to RecoveryInternational, and as President ofthe Malaysian Breast CancerCouncil (of which she is also thefounder), and of the Breast CancerWelfare Association.

Outstanding UICC memberorganisation

The Cancer Society of Finlandwas recognised for its contributionto Finnish public health policy,including the implementation ofnationwide cervical, breast andcolon cancer screening.The socie-ty was also responsible for the cre-ation of the hospice network inFinland in 1985.

UICC Awards for excellence inglobal cancer control

Dr Leslie Sobin Micheál Martin with Isabel Mortara

Ranjit Kaur with Isabel Mortara

Presentation to the Cancer Society ofFinland

To recognise individuals and organisations who have significantly contributed to global cancercontrol, the International Union Against Cancer presented four awards in 2004.

UIC

C A

nnua

l Rep

ort

2004


Cancer in the Developing World

Cairo, Egypt, 21-25 March 2005Hosted by the National Cancer Institute-Egypt, Cairo University, theFakkous Centre for Cancer and AlliedDiseases and the Egyptian Foundation forCancer Research.

Today’s Reality, Tomorrow’sPerspectives

13th Reach to RecoveryInternational Breast CancerSupport ConferenceAthens, Greece, 1-4 June 2005

Hosted by the Hellenic Association ofWomen with Breast Cancer and theSociety of Volunteers Against Cancer.

Beyond Information: IncreasingEfficacy in Prevention

Montpellier, France, 23-24September 2005

This seminar, to be held in the third quar-ter of 2005, will be hosted by the FrenchNational League Against Cancer and theEpidaure Centre in Montpellier.

Bridging the Gap: TransformingKnowledge into Action

World Cancer CongressWashington DC, USA, 8-12 July 2006

The UICC World Cancer Congress willbring together the world's leaders in the

fight to control cancer. It will focus ontransforming the latest knowledge intostrategies that countries, communities, insti-tutions and individuals can employ toreduce the cancer burden.

One of the five tracks will highlight theadvances, challenges and barriers to provid-ing supportive care to cancer patientsworldwide.A second track on buildingcapacity in cancer organisations will inte-grate the UICC World Conference forCancer Organisations into the Congress.Other tracks will cover cancer research,detection and treatment; public health, pre-vention and education; and tobacco andcancer.

The Congress will be followed on 12-15July 2006 by the 13th World Conferenceon Tobacco OR Health, with a crossoverday on Tuesday 12 July. See www.2006confer-

ences.org

Jagruti, the Awakening

3rd Asia-Pacific Reach to RecoveryInternational Breast CancerSupport Conference Mumbai, India, 7-10 November 2006

Hosted by the Mastectomees Association ofIndia, this conference aims to bring togeth-er breast cancer survivors, newly diagnosedwomen and health-care workers to shareinformation, experiences and skills particu-lar to the region.

UICC Conferences in 2005 and beyond


ArgentinaLiga Argentina de Lucha Contra el Cáncer (LALCEC)

AustraliaCancer Council ACT; Cancer Council Australia;Cancer Council New South Wales; CancerCouncil Northern Territory; Cancer CouncilSouth Australia; Cancer Council Tasmania;Cancer Council Victoria; Cancer CouncilWestern Australia; National Cancer ControlInitiative; Peter MacCallum Cancer Institute;Queensland Cancer Fund; Walter and Eliza HallInstitute of Medical Research

BahrainBahrain Cancer Society

BangladeshBangladesh Cancer Society

BelgiumBelgian Federation against Cancer; EuropeanSociety of Therapeutic Radiology & Oncology(ESTRO); Oncological Centre Antwerp (OCA)

BoliviaFundación Boliviana Contra el Cáncer

BrazilAssociação Brasileira Assistencia aos Canceros;Fundação Oncocentro de São Paulo; GrupoBrasileiro de Estudos do Câncer; InstitutoNacional do Câncer (INCA); Instituto Brasileirode Contrôle do Câncer; Liga Bahiana Contra oCâncer; Sociedade Brasileira de Cancerologia;University of São Paulo

CanadaBritish Columbia Cancer Agency; CanadianAssociation of Radiation Oncologists; CanadianCancer Society; Cancer Care Ontario; Centre forChronic Disease and Prevention; FondationQuébécoise du Cancer; National CancerInstitute of Canada; Princess Margaret Hospital

ChinaChinese Anti-Cancer Association (CACA);Chinese Medical Association; Hong Kong Anti-Cancer Society; Tianjin Medical UniversityCancer Institute and Hospital

ColombiaLiga Colombiana Contra el Cáncer

Croatia Croatian League Against Cancer

CubaInstituto Nacional de Oncología y Radiobiología

CyprusCyprus Anti-Cancer Society; Cyprus Associationof Cancer Patients and Friends

Czech RepublicLeague Against Cancer

DenmarkDanish Cancer Society

Dominican RepublicLiga Dominicana Contra el Cáncer; PatronatoCibaeño Contra el Cáncer

EcuadorSociedad de Lucha contra el Cáncer (SOLCA)

EgyptFakkous Centre for Cancer and Allied Diseases;National Cancer Institute

El SalvadorInstituto del Cáncer de El Salvador

EstoniaEstonian Cancer Society

FijiFiji Cancer Society

FinlandCancer Society of Finland

FranceCentre d'Oncologie Léon Bérard; CentreGeorges-François Leclerc; Centre RégionalFrançois Baclesse; Centre Régional Jean Perrin;

Centre Régional Paul Papin; Centre RenéGauducheau; Centre René-Huguenin; ComitéDépartemental de l'Aube; ComitéDépartemental des Hauts-de-Seine; ComitéDépartemental de la Savoie; ComitéDépartemental des Yvelines; Comité Nationalpour les Relations avec l'UICC; EpidaureC.R.L.C. Val d'Aurelle-Paul Lamarque;Fédération Nationale des Centres de Lutte con-tre le Cancer (FNCLCC); Institut ClaudiusRegaud; Institut Curie; Institut Gustave Roussy;Institut Jean-Godinot; Institut Paoli Calmettes;Ligue Nationale, Comité de Paris; LigueNationale Contre le Cancer; Société Françaisedu Cancer

GeorgiaNational Cancer Centre of Georgia

GermanyDeutsche Krebsgesellschaft e.V.; DeutscheKrebshilfe; Deutsches Krebsforschungszentrum(DKFZ); Westdeutsches Tumorzentrum (WTZE)

GreeceHellenic Cancer Society; Hellenic Society ofOncology

GuatemalaLiga Nacional Contra el Cáncer Guatemala/Piensa

HondurasAsociación Hondureña de Lucha contra elCáncer; Liga Contra el Cáncer

HungaryHungarian League Against Cancer

IcelandIcelandic Cancer Society

IndiaBangalore Institute of Oncology; Cancer CentreWelfare Home and Research Institute; CancerInstitute (WIA); Cancer Patients Aid Association;Dharamshila Cancer Hospital; Dr B. BorooahCancer Institute; Gujarat Cancer and ResearchInstitute; Indian Cancer Society; Institute ofCytology and Preventive Oncology; InstituteRotary Cancer Hospital (IRCH); KidwaiMemorial Institute of Oncology; Meherbai TataMemorial Hospital; Rajiv Gandhi CancerInstitute and Research Centre; Tata MemorialCentre

IndonesiaIndonesian Cancer Foundation

IranCancer Institute, Imam Khomeini MedicalCentre; Research Centre of Gastroenterologyand Liver Transplantation; Shariati Hospital,HORC

IrelandIrish Cancer Society

IsraelIsrael Cancer Association

ItalyAssociazione Italiana di Oncologia Medica(AIOM); Associazione Italiana Malati di CancroParenti e Amici (AIMAC); Associazione Italianaper la Ricerca sul Cancro; Centro di PrevenzioneOncologica (CPO); Centro di RiferimentoOncologico; Centro per lo Studio E laPrevenzione Oncologica; European Institute ofOncology; European School of Oncology;Istituto di Ricerche Farmacologiche "MarioNegri"; Istituto Nazionale per la Ricerca sulCancro (IST); Istituto Nazionale per lo Studio e laCura dei Tumori; Istituto Nazionale per lo Studioe la Cura dei Tumori. Fondazione "G. Pascale";Istituto Oncologico Romagnolo; Lega Italianaper la Lotta Contro I Tumori; Regina ElenaCancer Institute; Università degli Studi dell'Insubria; Università degli Studi di Perugia

JapanAichi Cancer Centre; Cancer Institute of JFCR;Chiba Cancer Centre; Children's CancerAssociation of Japan; Fukuoka Cancer Society;Hokkaido Cancer Society; Institute of Cellularand Molecular Biology; Japan Cancer Society;Japan Foundation of Multidisciplinary CancerTreatment; Japan Lung Cancer Society; JapanSociety of Clinical Oncology; Japanese CancerAssociation; Jikei University School of Medicine;Kanagawa Cancer Centre; Miyagi CancerSociety; Nagoya Memorial Hospital; NiigataCancer Centre; Osaka Cancer Foundation;Osaka Medical Centre for Cancer andCardiovascular Diseases; Princess TakamatsuCancer Research Fund; Saitama Cancer Centre;Sapporo Cancer Seminar Foundation; Sasaki

Country with Members

UICC Member Organisations

UIC

C A

nnua

l Rep

ort

2004


Institute and Foundation; Science Council ofJapan; Tochigi Cancer Centre; Tokyo MetropolitanKomagome Hospital

JordanKing Hussein Cancer Centre

KenyaKenya Cancer Association

Korea, Republic ofKorea Institute of Radiological and MedicalSciences (KIRAMS); Korean Cancer Society;National Cancer Centre Research Institute

KuwaitKuwait Society for Smoking and CancerPrevention (KSSCP)

LatviaAugust Kirchenstein Institute of Microbiology andVirology

LebanonLebanese Cancer Society

LithuaniaLithuanian Anti-Cancer Association

LuxembourgMinistère de la Santé

MalaysiaNational Cancer Council (MAKNA); NationalCancer Society of Malaysia

MexicoAsociación Mexicana de Lucha Contra el Cáncer,AC; Instituto Nacional de Cancerología; SociedadMexicana de Oncología, AC

MongoliaNational Oncological Centre

NamibiaCancer Association of Namibia

NepalB.P. Koirala Memorial Cancer Hospital; NepalCancer Relief Society (NCRS)

NetherlandsAcademisch Medisch Centrum; Dutch Associationof Comprehensive Cancer Centres (ACCC); DutchCancer Society; Netherlands Cancer Institute

New ZealandCancer Society of New Zealand

NigeriaNigerian Cancer Society

NorwayNorwegian Cancer Society

OmanMinistry of Health

PakistanMinistry of Health; Biosciences Division,Pakistan Atomic Energy Commission (PAEC)

PanamaAsociación Nacional Contra el Cáncer

PeruInstituto de Enfermedades Neoplásicas; LigaPeruana de Lucha Contra el Cáncer; OncosaludSAC; Sociedad Peruana de Cancerología;Sociedad Peruana de Oncología Médica

PhilippinesPhilippine Cancer Society

PolandInternational Hereditary Cancer Centre; PolishOncological Society

PortugalInstituto Português de Oncologia de FranciscoGentil; Liga Portuguesa Contra o Cancro

RomaniaInstitute of Oncology "Al Trestioreanu"

RussiaN.N. Blokhin Cancer Research Centre

Saudi ArabiaMinistry of Health

Serbia and MontenegroSerbian Society for the Fight Against Cancer

SingaporeNational Cancer Centre; Singapore CancerSociety

SlovakiaSlovak League Against Cancer

SloveniaAssociation of Slovenian Cancer Societies;Institute of Oncology

South AfricaCancer Association of South Africa

SpainAsociación Española Contra el Cáncer;Asociación Vivir Como Antes; Institut Catalàd'Oncologia

SwedenCancer Society in Stockholm; Swedish CancerSociety

SwitzerlandKrebsliga Schweiz/Ligue suisse contre le cancer;Swiss Institute for Experimental Cancer Research(ISREC)

SyriaSyrian Cancer Society

TaiwanChinese Oncology Society (COS); FormosaCancer Foundation; John Tung Foundation;Taiwan Cancer Society

ThailandNational Cancer Institute; Thai Cancer Society

Trinidad and TobagoTrinidad and Tobago Cancer Society

TunisiaAssociation Tunisienne de Lutte contre leCancer; Institut Salah Azaiz

TurkeyTurkish Association for Cancer Research andControl

United KingdomBritish Association for Cancer Research; BritishAssociation of Surgical Oncology (BASO);Cancer Research UK; CancerBACUP; CochraneCancer Network; The Institute of CancerResearch; Lymphoma Coalition; MacmillanCancer Relief; Marie Curie Cancer Care; ThePaterson Institute for Cancer Research; UlsterCancer Foundation; World Cancer ResearchFund

UruguayComisión Honoraria de Lucha contra el Cáncer;Hospital de Clínicas "Dr. Manuel Quintela"

USAAlbert C. and Bertha P. Markstein CancerEducation and Prevention Center; AmericanAssociation for Cancer Research; AmericanCancer Society; American College of Radiology;American College of Surgeons Commission onCancer; American Head and Neck Society;American Society of Clinical Oncology;American Society for Therapeutic Radiology andOncology (ASTRO); Arthur G. James CancerHospital Research Institute; C-Change (NationalDialogue on Cancer); Cabrini Medical Center;Centers for Disease Control & Prevention(CDC); College of American Pathologists; FredHutchinson Cancer Research Center; Gerald P.Murphy Cancer Foundation; H. Lee MoffittCancer Center; Huntington Medical ResearchInstitute; International Society for the Study ofComparative Oncology; Kellogg Cancer CareCenter; Lance Armstrong Foundation; MasseyCancer Center; M.D. Anderson Cancer Center;National Cancer Institute (USA); NationalCenter for Tobacco-Free Kids; OncologyNursing Society; Roswell Park Cancer Institute;Society of Surgical Oncology; Susan G. KomenBreast Cancer Foundation

VenezuelaSociedad Anticancerosa de Venezuela

VietnamNational Cancer Institute (Vietnam)

ZimbabweCancer Association of Zimbabwe

InternationalInternational Extranodal Lymphoma StudyGroup; International Ostomy Association;International Psycho-Oncology Society; LudwigInstitute for Cancer Research

Global Action Against Cancer


Aoki, KunioBaity, JohnBarrett, AnnBeltran Ortega,ArturoBrawer, MichaelBrien, GraemeBurger, MaxBurn, I.Burton, RobertCerutti, P.Charlton, AnneCiechanover, A.Collan, YrjöCollins, V.Das, Samirande Nuñez, IsabelDenis, LouisDietel, M.Dinshaw, KetayunEckhardt, SandorElovainio, L.Etukudo, M.Grammatica, L.Gray, NigelGrivegnée, AndréHakama, MattiHanks, GeoffreyHann, ByronHansen, H.Heppner, GloriaHöffken, K.Höfler, H.Hoskins, WilliamHutter, RobertIhse, IngemarImai, KohzohJonas, A.

Junqueira, AntonioKavanagh, JohnKikuchi, KokichiKim, Jin-PokKrasna, MarkLawrence, WalterLenhard, RaymondLevin, B.Littbrand, BoLlombart-Bosch, A.Lucas, G.Magrath, I.Mayer, ZahariaMetcalf, DonaldMickelson, H. FredMihich, EnricoMirand, EdwinMittra, IndraneelMiwa, M.Morgan, MichaelMusé Sevrini, I.Nambiar, RajNilsson, KennethNister, MonicaOspina, J.Pavlovska, IrinaPeters, L.Ragde, H.Rajewsky, ManfredRingborg, UlrikRobinson, EliezerRosenthal, DavidRudolf, ZvonimirRuiz de Campos,LissethRutqvist, L.Sasaki, RyuichiroSchmidt, C.

Seffrin, J.Sekhar, LaligamSenn, HansShah, JatinSheldrick, P.Sobin, LeslieSoedoko,RoemwerdinjadiSriplung, HutchaSrivastava, P.Storme, G.Sugarbaker, PaulTaguchi, TetsuoTahara, EiichiTang, Zhao-YouTattersall, MartinThomas, JoséTominaga, SuketamiToyoshima, K.Trichopoulos, D.Tsuchida, NobuoUllrich, Axelvan der Walt, RikaVazquez Rosas,TabareWeber, WalterWilkinson, SusieWoelkers, JosephXu, GuangYuile, P.Zaridze, Davidzur Hausen, Harald

UICC Roll of Honour

Through the Roll of Honour, UICC and itsmember organisations recognise and acknowledge the outstanding commit-ment and achievements in the fight againstcancer of individuals throughout the world.As individual members of UICC, these dis-tinguished scientists, clinicians, care profes-sionals and volunteers support UICC activi-ties with an annual membership donation of$250. All UICC member organisations areencouraged to honour the outstandingachievements of their own staff and volun-teers by sponsoring them for Roll of Honour membership and assuming their annualdonation.

List of Members

Corporate members

UICC is grateful to the corporate memberswho have supported the four strategic

directions of Prevention and Early Detection,Tobacco Control, Knowledge Transfer andCapacity Building via unrestricted grants.Many of the activities described in the annu-al report would not have happened withouttheir support.

Corporate membership is open to leaders ofthe medical supply and technology, pharma-ceutical, biotechnology and health publishingindustries and other private sector companies.

Novartis Oncology

Bristol-Myers Squibb

sanofi-aventis Pfizer

Purdue Pharma Mundipharma

John Wiley & Sons

UIC

C A

nnua

l Rep

ort

2004


Task Forces

Prevention andEarly DetectionStrategic Leader: Dr HélèneSancho-Garnier (all sub-groups)

Strategic Direction Steering GroupDr Basil BlochDr Robert BurtonDr Karen Slama

Cancer Registration Task ForceDr Mokhtar Hamdi-CherifMrs Martha OlivaDr Paola PisaniDr Roberto Zanetti

Evidence-Based CancerPrevention: Strategies for NGOsTask ForceProf Annie AndersonDr Andreas BiedermannDr Elsebeth LyngeDr Karen Slama

Promoting Evidence-BasedInterventions Task ForceDr Arun KurkureDr Lisseth de CamposDr Maria Paula CuradoDr Catterina FerrecioDr Marion Pineros Petersen

Oversight Committee UICC LatinAmerica Cervical Cancer PilotProjectDr Basil BlochDr Eduardo CaceresDr Stener KvinnslandMrs Martha OlivaDr Carlos SantosDr Odd Søreide

Tobacco ControlStrategic Leader: Mr YussufSaloojee (all sub-groups)

Tobacco Control MembershipWorking Group 2004Dr David BristolMr Mike DaubeMr Liisa ElovainioDr Tom GlynnDr Nigel GrayDr Prakash GuptaMr Andrew HayesDr Albert HirschMs Jean KingMr Ken KyleMr Fred MickelsonDr Sherif OmarMr Mike Pertschuk (ex officio)Ms Denise SullivanDr Witold ZatonskiMs Miri Ziv

GLOBALink Tobacco ControlWorking Group

Dr Simon ChapmanDr Alex JadadDr Sinead JonesMs Sylviane RatteMr David SimpsonDr Anthony So

Vision/Issue Working Group

Ms Cynthia CallardMs Shoba John

Mr Luk JoosensMr Matth MyersMr Mike PertschukMr David SweanorProf Ken WarnerMs Judy Wilkenfield

Knowledge TransferStrategic Leader: Dr KennethNilsson

Knowledge Transfer SteeringGroup

Dr Kenneth NilssonDr Mary GospodarowiczDr Arun KurkureDr Peter KrammerDr Raphael PollockDr Susie Wilkinson

UICC Fellowships - ReviewersTask Force

Dr Neil AaronsonDr Garry AbelevDr Hans-Olov AdamiDr Michael AgrezDr Wynne AherneDr Sam AhmedzaiDr M. AitchisonDr Valentine AndelaDr Jonathan AndersonDr Neil AndersonDr Ingvar AnderssonDr Leif AnderssonMs Emily AngDr V. AnisimovDr Alan AnthoneyDr S. ArbuckDr Arja AroDr Johan AschanDr Dan AshDr Margaret AshcroftDr Alan AshworthDr Herman AutrupDr Diana Averill-BatesDr Hava AvrahamDr Baffour AwuahDr Malcolm BagshawDr Peter Barrett-LeeDr Chris BartholomewDr J. Bar-ZivDr Michel BeaugrandDr Colin BegleyDr John BellDr Uziel BellerDr Roland BergerDr M. BergstromDr Lev BersteinDr Joseph BertinoDr Istvan BesznyakDr Peter BeverleyDr Peter BiberfeldDr Margaret BidmeadDr M. BirchallDr Peter BlakeDr A. BoddyDr Paolo BoffettaDr G. BomanDr Cristina BosettiDr Penelope BouziotisDr David BowtellDr J. BoydDr Marie BoydDr Michael BradaDr Alexander BrehmDr Harold BrennerDr David BrewsterDr Graham Brock

Dr Robert BrownDr Tim BrummendorfDr Valerie BruntonDr E. BuarqueDr Jan BubenikDr Angelika BurgerDr Arsene BurnyDr C. BuschDr Federico Caligaris-CappioDr David CameronDr M. Saveria CampoDr Angelo CarellaDr Natale CascinelliDr Webster CaveneeDr D. CellaDr Marcel ChatelDr J. ChattopadhyayaDr Chen MinhuaDr Kent ChuDr Stefano CiattoDr Lena Claesson-WelshDr Alan CoatesDr J. CoderreDr Andrew CollinsDr T. CookeDr Charles CoombesDr Colin CooperDr J. CowanDr Catherine CoyleDr L. CozziDr Dorothy CrawfordDr Bernard CummingsDr Jack CuzickDr Maurizio D IncalciDr A. DalgleishDr H DavisDr Giuseppe De PaloDr Adriano DecarliDr Charles DeehanDr Helmut DeisslerDr William DennyDr M. DiazDr Joakim DillnerDr Gerald DoddDr T. DolecekDr Julie DoughtyDr Derek DoyleDr P. DruetDr Mark DrummondDr Mark DuffyDr Jeff DunnDr C. EavesDr Suzanne EcclesDr Alexander EggermontDr F. EilberDr Lea EisenbachDr Peter EkblomDr Anders EkbomDr John William EleyDr M. ElkindDr E. El-OmarDr G. EvansDr Jeff EvansDr Doriano FabbroDr S. FanDr P. FarrellDr Ludwig FeinendegenDr Ian FentimanDr Manlio FerrariniDr Silvano FerriniDr Malcolm FinbowMs Margaret FitchDr Brian FlynnDr David FormanDr Silvia FranceschiDr Juan FrontrothDr Grant FullartonDr Francis GalibertDr Timothy GantDr Gao YutangDr Silvio Garattini

Dr J. GazetDr Benjamin GeigerDr A. GescherDr A. GianniDr S. GilmourDr L. GissmannDr Rosalind Given-WilsonDr Bengt GlimeliusDr C. GodingDr James GoingDr David GoldgarDr John GrahamDr Gerry GrahamDr William GrantDr M. GreavesDr C. GrecoDr John GreenDr Anna GregorDr Henri GrosjeanDr Alan GrundyDr Jose Guimaraes Dos SantosDr Barry GustersonDr Angela HagueDr Neva HaitesDr Andrew HallDr Janet HallDr B. HancockDr Prakash HandeDr Joe HarfordDr Clive HarmerDr Paul HarrisonDr Andrea HartwigDr Gerard HastingsDr Karin HaustermansDr Carl HeldinDr Carl-Henrik HeldinDr B. HendersonDr Michel Henry-AmarDr Robert HerdDr Simon HerringtonDr Steve HeysDr Rodney HicksDr Irene HigginsonDr Fred HirschDr Malcolm HodginsDr K. HöffkenDr Nicholas HoleDr Jimmie HollandDr L. HolmgrenDr Jarrod HomerDr Martin HooperDr Kirsten HopkinsDr Robert HuddartDr C. HungDr Cathy HutchisonDr Ingemar IhseDr Sadao IkedaDr Masayuki ImamuraDr Beat ImhofDr C. ImrieDr Pilar IniestaDr Kaichi IsonoDr R. IsselsDr J. IzbickiDr Marja JaattelaDr Ann JackmanDr Nicholas JamesDr R. JamesDr O. JarrettDr Ruth JarrettDr Karl JauchDr Luis Jimenez de AsuaDr D. JodrellDr Bertil JohanssonDr H. JohanssonDr Judith JohnsonDr Patrick JohnstonDr Richard JonesDr Elizabeth JunorDr Antonio JunqueiraDr S. Kaasa

Dr R. KanamaruMs Alka KapadiaDr Gertjan KaspersDr Fujio KasumiMs Ranjit KaurDr Nicol KeithDr W. KeithDr Christopher KempDr Vincent KhooDr D. KillanderMs Jean KingDr Judith KingstonDr Roger KirbyDr Masaki KitajimaDr George KleinDr Alfred KnudsonDr Uwe KochDr Pasi KoivistoDr Walter KolchDr Boris P. KopninDr Leopold KossDr Itamar KottDr Gyula KovacsDr Malgosia KrasuskaDr Andris KreicbergsDr K. KrügerDr Ada KruisbeekDr Andrzej KulakowskiDr Rakesh KumarDr Abraham KutenDr Carlo La VecchiaDr Sunil LakhaniDr R. LamerzDr E LarssonDr Eduardo LauraDr Jonathan LedermannDr Veli LehtoDr J. LemerleDr R. LeonardDr Peter LevendagDr F. LéviDr Li ChunhaiDr Thomas LindahlDr Annika LindblomDr B. LindequeDr Joachim LingnerDr Thomas ListerDr Johné LiuDr Lo Chung-MauDr Dennis LoDr J. LoefflerDr Eugene LukanidinDr Kuauhyama Luna OrtizDr E. LundgrenDr Melissa LuwiaDr Anne LykkesfeldtMs Fiona MacGregorDr R. MackayDr Mike MackettDr Rona MacKieDr Krishnan Madhavan NairDr Alicia MagarinosDr P. MaguireDr Robert MairsDr Nils MandahlDr Q. Nguyen ManhDr Marc MareelDr G. MargisonDr Phil MasonDr Wolrad MattheiemDr Christoph MaurerDr A. McGowanDr Alan McKayMs Myrna McLaughlin AndersonDr Howard McLeodDr Nigel McMillanDr Hakan MellstedtDr Fredrik MertensDr Donald MetcalfDr K. MetodievDr Ralph MeyerDr Mark Middleton

Dr E. MihichDr Bernard MijnheerDr William MillerDr Robert MilroyDr Felix MitelmanDr Harsh MohanDr Göran MöllerMs Pearl MooreDr Sally MorganDr David MorrisDr Randall MortonDr Henning MouridsenDr Alastair MunroDr J. MurrayDr Arnon NaglerDr Tsuguo NarukeDr Eva NegriDr Munro NevilleDr Vu Quoc NguyenDr Ole NielsenDr Kenneth NilssonDr Olle NilssonDr Tetsuo NodaDr Magnus NordenskjoldDr Franz OeschDr Adenike OnibokunDr Willem OosterlinckDr Susanne OsantoDr Wolfram OstertagDr B. OzanneDr Lars PahlmanDr Valerio ParisiDr Chris ParkerDr Peter ParkerDr Rowan ParksDr Nitin PatelDr R. PayneDr Mick PeakeDr Carlos PerezMs Sabine Perrier-BonnetDr Gordon PetersDr Olé PetersenDr Ruth PettengellDr Ulf PetterssonDr Herbert PfisterDr David PhillipsDr Paola PisaniDr Christoph PlassDr K. PlattDr Miriam PoirierDr Christopher PottenDr Barry PowellDr Judy PowellDr Pat PriceDr E. PuréDr Om PurohitDr A. PurushothamDr David QuinnDr Manfred RajewskyDr Muchlis RamliDr Rao BhaskarDr Zenon RayterDr Nicolas ReedDr Robin ReidDr A. RickinsonDr A. RobertsonDr Diane RobinsDr A. RocheDr Piere RogallaDr Jens RohrbachDr Göran RoosDr Geoff RoseDr Marianne RotsDr J. RoweDr Paul RozenDr Marc RudoltzDr Curzio RüeggDr Anders RydholmDr Leo SachsDr M. SacksDr Nigel SacksDr Azmat Sadozye

Dr Korinn SakerDr Mudan SatvinderDr M. SchartlDr Andreas SchätzleinDr Werner ScheithauerDr Rik ScheperDr Volker SchirrmacherDr Anne Schmitt-VerhulstDr Bernadette SchoketDr V. SchumpelickDr Reinhard Schwartz-AlbiezDr Andrew ScottDr Crispian. ScullyDr S SeeberDr Peter SharpDr Denise SheerDr John ShepherdDr Ben-Zion ShiloDr Janet ShipleyDr Shi-Xin LuDr A. SiegbahnDr Jorg SiewertDr Paul SimmonsDr Bengt SimonssonDr Freddy SitasDr S. SlavinDr Nicholas SlevinDr Alexander SobolevDr Alberto SobreroDr Jens SorensenDr Thierry SoussiDr David SoutarDr Demetrios SpandidosDr Valérie SpeirsDr Stephen SpiroDr E. StanbridgeDr Michael SteelDr R. SteinDr Bo StenerlowDr John StevensDr M. StevensDr John StewardDr William StewardDr Bernard StewartDr Hans StormDr Ronald StoutDr Hans StranderDr Ian StratfordDr Gordon StrathdeeDr Robert StuartDr George StudzinskiDr Robert SudderickDr Christer SundstromDr Robert SutherlandDr Andrew SykesDr R. SymondsDr Kari SyrjanenDr Paul TalalayDr Li TanDr Gunnar TanumDr Stephen TaylorDr Joel TepperDr Bruce ThomadsenDr Hilary ThomasDr José ThomasDr Valerie ThomasDr John ThompsonDr Magnus ThornDr Pierre TiollaisDr Matthias TischDr J. TrowsdaleDr I. TuressonDr Aysegul UnerDr Martin Van den BentDr A. Van der EbDr Ate van der ZeeDr Paul Van DiestDr Allan Van OosteromDr Hendrik Van PoppelDr Paul VaseyDr Keith VassDr Georges Vassaux

Dr A. VeermanDr Aldo VenutiDr Marcel VerheijDr Sally VernonDr Luisa VillaDr Sabine von KleistDr Stefaan VynckierDr Jürgen WahrendorfDr Paul WaringDr Roger WatsonDr D. WazerDr Steve WebbDr William WeiDr Eva Weiler-MithoffDr Mary WeissDr M. WeitznerDr I. WernerDr Jochen WernerDr C. WestDr Matthew WestDr B. WestermarkDr Robert WhiteDr Erik WilanderDr Christopher WildDr A. WileyDr Laura WilkinsonDr Susie WilkinsonDr K. WilleckeDr A. WilliamsDr Gareth WilliamsDr Charles WilsonDr Penella WollDr John WongDr Richard WoosterDr Eric WrightDr Wei XiaoDr Hiroshi YamasakiDr Yang KeDr You WeichengDr Bryan YoungDr Lawrence YoungDr Ilana YronDr J. YuenDr Nadia ZaffaroniDr Michael ZalutskyDr Zhang YouhuiDr Zheng EhDr Zheng ShuDr Zhu JingdeDr Olga ZhukovaDr Robert Zimmerman

TNM Prognostic Factors CoreGroupDr Leslie H. Sobin (Chair)Dr Ellen Benhamou-BorowskiDr James BrierleyDr Louis Jean DenisDr Carol FriedmanDr Mary GospodarowiczDr Frederick L. GreeneDr Patti A. GroomeDr Daniel MillerDr Hextan Y.S. NganDr Kenneth NilssonDr Brian O'SullivanDr Christian WittekindDr Susumu Yamasaki

TNM Process Task ForceDr Mary Gospodarowicz (Chair)Dr Carol FriedmanDr Frederick L. GreeneDr Patti A. GroomeDr Daniel MillerDr Hextan NganDr Leslie H. Sobin

TNM Prognostic Factors TaskForceDr Mary Gospodarowicz (Chair)


Dr Douglas G. AltmanDr Carol FriedmanDr Frederick L. GreeneDr Patti A. GroomeDr Daniel MillerDr Brian O'SullivanDr Leslie H. SobinDr Christian Wittekind

TNM Supplement Editorial TaskForceDr Christian Wittekind (Chair)Dr Leslie H. SobinDr Susumu Yamasaki

TNM Atlas Editorial Task ForceDr Christian Wittekind (Chair)Dr Frederick L. GreeneDr Leslie H. SobinDr Susumu Yamasaki

UICC Manual of ClinicalOncology 8th editionEditorsDr Raphael E. Pollock (Chair)Dr James H. DoroshowDr David KhayatDr Akimasa NakaoDr Brian O'Sullivan

Cancer Basics Task ForceDr Susie Wilkinson (Chair)Ms Emily AngMs Petra FordelmanDr Malgosia KrasuskaMs Bhagavathi KrishnaMs Myrna McLaughlin Anderson

TNM Expert Panel 2004

Breast PanelDr Tim WhelanDr Ian EllisDr Stephen B. EdgeDr Patrick L. FitzgibbonsDr Daniel F. HayesDr Eva Sonja Singletary

Gastro intestinal PanelDr Carolyn ComptonDr Bernard CummingsDr. Philip J. JohnsonDr Günter KlöppelDr Christian WittekindDr Tadakazu ShimodaDr. Jan W.H. LeerDr Norman CarrDr John PrimroseDr Jorge Albores SaavedraDr Alfred M. CohenDr Cecilia Fenoglio PreiserDr J. Milburn JessupDr Thian Lok TioDr Stuart J. SpechlerDr Sidney J. Winawer

Genito urinary PanelDr Louis Jean DenisDr Hideyuki AkazaDr Adrian van der MeijdenDr Fernando AlgabaDr Dean BajorinDr James MontieDr Alan PollackDr Mack Roach IIIDr Ian Thompson

Gynaecologic PanelDr J. Lou BenedetDr Anthony FylesDr Hextan Y.S. NganDr Sergio Pecorelli

Dr William T. CreasmanDr William J. HoskinsDr Maurie Markman

Head and Neck PanelDr Steve HallDr Brian O'SullivanChina Dr John K.C. ChanChina Dr Anne W.M. LeeDr Vincent F.H. ChongDr John EvesonDr E. Leon BarnesDr Jesus MedinaDr Suresh MukherjiDr Jatin P. Shah

Lung PanelDr David BallDr Michael BrundageDr Frances ShepherdDr Thierry Le ChevalierDr Roysuke TshuchiyaDr Peter GoldstrawDr Ned PatzDr Valerie W. RuschDr William D. Travis

Lymphoma PanelDr Andrew WirthDr Lena SpechtDr Emanuele ZuccaDr Alan HorwichDr Andrew ListerDr James O. ArmitageDr Richard HoppeDr Peter Mauch

Sarcoma/Bone PanelDr Peter ChoongDr Robert S. BellDr Brian O'SullivanDr Cyril FisherDr Ian JudsonDr Peter W.T. PistersDr Raphael E. PollockDr Sharon Weiss

Skin PanelDr Peter HeenanDr Michael G. PoulsenDr John ThompsonDr Richard TsangDr Natale CascinelliDr David ElderDr Philip E. LeBoitDr Martin C. MihmDr George Murphy

TNM National Committees2004

BelgiumDr Louis Jean Denis (Chair)

CanadaDr James Brierley (Chair)Dr Audley BodurthaDr Carolyn ComptonDr Pierrre DrouinDr Dagny DryerMs Maureen MacIntyreDr John Srigley

FranceDr Ellen Benhamou Borowski

Germany/AustriaDr H.J. Meyer (Chair)Dr Martin KlimpfingerDr Elfriede BollschweilerDr F. Bootz

Dr H. BreuningerDr H. DralleDr Peter DringsDr E. DühmkeDr P. EyselDr C. GarbeDr N. GrafDr G. JakseDr P. HermanekDr H.P. HowaldtDr Th. JungingerDr J. KiwitDr U. MansmannDr C. MohrDr H.D. SaegerDr Dietrich von SchweinitzDr C.W. SpraulDr G.A. WagnerDr A. WeberDr P. WirthDr C. Wittekind

ItalyDr Fausto Badellino (Chair)Dr Giovanni AnaveriDr Pierluigi Benedetti PaniciDr Marcello CanaleDr Manuel A. CastelloDr Francesco CianfrigliaDr Anna Di IorioDr Mauro DimitriDr Andrea ForestieriDr Massimo GaspariniDr Roberto GiardiniDr Domenico MessinaDr Guido MosellaDr Lucio MianoDr Giuseppe PaladiniDr Marco PiemonteDr Paolo PronzatoDr Marco RosaDr Nicolo ScuderiDr Vincenzo StipaDr Fabio VolterraniDr Paolo Zola

JapanDr Susumu Yamasaki (Chair)Dr Yasuo BeppuDr Shin ichi EgawaDr Takashi HayashiDr Iwao IkaiDr Akihiro KanekoDr Hitoshi KataiDr Takahiro KasamatsuDr Takayuki KinoshitaDr Kenjiro KotakeDr Kiyoshi MukaiDr Takukazu NagakawaDr Yoshitaka OkamotoDr Hisanao OokuraDr Masahisa SaikawaDr Souichirou ShibuiDr Yuji TachimoriDr Takashi WatanabeDr Akifumi Yamamoto

RussiaDr Nikolay N. Blinov (Chair)

USADr Frederick L. Greene (Chair)

Capacity BuildingStrategic Leader: Dr RobertBurton (all sub groups)

Capacity Building OversightGroupDr Louis DenisDr Kate Dinshaw

Dr Jeff DunnProf Hélène Sancho-GarnierDr Yip Cheng HarMr Michael F. HeronMr Tom HudsonDr Melissa LuwiaDr Yussuf Saloojee

National Cancer Control StrategicPlanning Task ForceDr Mark ElwoodDr Arun KurkureDr Eliezer RobinsonJanine Nesset TominagaDr Thierry PhilipDr Sherif Omar

Network Development Task ForceMs Catherine DickensMr Tom HudsonMs Ranjit KaurDr Roy West

Capacity Building Materials TaskForceDr Jeff DunnMr Tom HudsonDr Melissa LuwiaMs Johanna RalstonMs Dorothy Reading

Patient Support Task ForceDr Jeff Dunn

Reach to Recovery CommitteeMs Ann SteynMs Miri ZivMs Maria Ines Marchegiani deUckeMs Irina KozulinaMs Karen VeienMs Maria MatosMs Alka Kapadia

Reach to Recovery NewsletterEditorial BoardMs Ranjit KaurMs Lohes RajeswaranDr Jeff DunnMr Tom HudsonMs Ann SteynMs Evelyn Zuberbühler

Conferences

UICC Advisory Group onInternational ConferencesDr Jeff Dunn (Chair)Dr Liisa ElovainioProf Helene Sancho-GarnierMr Michael F. HeronProf David Hill (Chair)Ms Pearl Moore

Membership

UICC Membership andGovernance Task ForceDr Mary Gospodarowicz (Chair)Mr John BaityDr Alan CoatesDr Louis DenisDr Kate DinshawDr Tomoyuki KitagawaMr Bruno MeiliDr Eliezer RobinsonDr John Seffrin (ex officio)

UIC

C A

nnua

l Rep

ort

2004


eUICC

eUICC Think TankDr Mary GospodarowiczMs Isabel MortaraMr Ruben IsraelMs Lisa BeroDr Rafa BravoDr Enrico CoieraDr Andrea A. CortinoisDr Joan DzenowagisProf David H. GustafsonDr Alex JadadDr Arun KurkureMs Mary Ann LansangDr Raymond LenhardMs Nancy LorenziDr Silvana LucianiMs Doina LupeaDr William MackillopDr Daniel S. MillerDr Vic NeufeldDr Sylvia RoblesDr Jeremy Wyatt

International Journal ofCancer

International Journal of CancerEditorial BoardEditor in ChiefProf Harald zur Hausen

Associate EditorsHelmut BartschNorbert FusenigMagnus von Knebel DoeberitzPeter H. KrammerPeter LichterAnthony Miller

Managing EditorSherryl Sundell

Editorial BoardLauri A. AaltonenStuart A. ArsonsonKari AlitaloBruce ArmstrongMariano BarbacidJ. Carl BarrettWalter BirchmeierMina J. BissellMikhail V. BlagoskonnyThomas BoehmThierry BoonMaxM. BurgerWalter CaveneePelayo CorreaJack CuzickAlbert de la ChapelleWafik El-DeiryAdi F. GazdarWilliam E. GrizzleUlf GyllenstenCurtis C. HarrisCarl-Henrik HeldinJames G. HermanMonica HollsteinWaun K. HongPeter M. HowleyTadao KadizoeT. KishimotoPaul KleihuesAlexander KnuthStanley J. KorsmeyerCarlo La VecchiaDavid LaneGilbert M. LenoirArnold J. LevineFrederick P. LiLawrence A. Loeb

David MalkinC.J.L.M. MeijerKees MeliefIra MellmanPaul MeltzerPatrick S. MooreSteven A. NarodBrian J. NickoloffM. OrenDonald Maxwell ParkinRoger ReddelGuido ReifenbergerJanet D. RowleyErkki RuoslahtiKeerti V. ShahKunitada ShimotohnoMichael R. StrattonTadatsugo TaniguchiMasaaki TeradaIan TomlinsonP. VineisS.H. Yuspa


UICC Fellows 2004

Country Project Name

Albania ICR Dr Merita ZekaAlgeria ICR Dr Said Kenida Argentina ICR Dr Evangelina Agriello

ICR Dr Valeria Denninghoff ICR Dr Marta GoleniowskiICR Dr Dora Loria

Armenia ICR Dr Tina Kosakyan Australia ICR Dr Pritinder Kaur

ICR Dr Ralph Lindemann YY1 Dr David Bowtell YY1 Dr Graeme Walker

Belgium ACS Dr Steven De Vleeschouwer Belize ICR Dr Leonora Flowers Brazil ICR Dr Maria Achatz

YY2 Dr Marcelo De Franco Bulgaria YY2 Dr Milka Georgieva Cameroon ICR Dr Isaac Sandjong Tiechou Canada ICR Dr Nikita Makretsov China APC Dr Xin Deng

ICR Dr Fang Fang ICR Dr He-Cheng Li ICR Dr Man Wong YY2 Dr Randy Yat Choi Poon

Cuba ICR Dr Martha Fors ICR Dr Alexander Montenegro ICR Dr Aillette Mulet Sierra ICR Dr Carmen Viada Gonzalez

Czech Republic ICR Dr Pavel Soucek ICR Dr Julia Starkova

Egypt ICR Dr Medhat El Mallah ICR Dr Mohamed Nazmy

Finland TCR Dr Harriet Wikman Germany ICR Dr Christian Buschow

ICR Dr Constanze KarstGhana ION Ms Susanna Asiedu Greece ICR Dr Stavroula Baritaki

ICR Dr Vassilis Gorgoulis ICR Dr Christos Tsatsanis

Guatemala ION Dr America Galindo Tecun Iceland ICR Dr Thorgunnur Petursdottir India ACS Dr Anupam Mishra

APC Dr Arun ChouguleAPC Dr Chahna Gandhi APC Dr Dheeraj Gupta APC Ms Radhakrishnan Jayakrishnan APC Ms Sukdev Nayak ICR Dr Bhairun Acharya ICR Dr Amit Agarwal ICR Dr Ritu Agarwal ICR Dr Manzoor BandayICR Dr Chenchu Chandra ICR Dr M Chandrakumaran NairICR Dr Ansuman Chattopadhyay ICR Dr Eric Colbert ICR Dr Tarun Durga ICR Mr Natanasabapathi Gopishankar ICR Dr Rajesh Gupta ICR Dr Uma HandaICR Dr Madhabananda Kar ICR Dr Surender Kashyap ICR Dr Jayesree Kattoor ICR Dr Rachel Koshy ICR Dr Nathan Krishna Murthy ICR Dr Ramachandran Krishnakumar ICR Dr Kiran Kucheria ICR Dr Rajeev Kumar ICR Dr Anil Mandhani ICR Dr Anusheel Munshi ICR Dr Dattatraya MuzumdarICR Dr Velu NairICR Dr Sukdev Nayak ICR Dr Jai NeemaICR Dr Kumar Pathak ICR Dr Nimish Pillai ICR Dr Munusamy Rajendran ICR Dr Dana Rohitashwa ICR Dr Sunil Saini

UIC

C A

nnua

l Rep

ort

2004


ICR Dr Seema Sen ICR Dr Sanjiv Sharma ICR Dr Punit Shukla ICR Dr Baljinder Singh ICR Dr Jasbir Singh ICR Dr Gopi Solaiappan ICR Dr Arivazhagan Vasudevan ICR Dr Sathavahana Vattikonda ICR Dr Sankaranarayanan

Venkataraman ICR Dr Ramalingam Wunnava ION Ms Bhavaniamma Geetha KumariION Ms Radha Saini YY2 Dr Indra Dharmu

Indonesia APC Dr Sunarsih Sutaryo APC Ms Pangesti Wiedarti ION Ms Dewi Arini Hidayah

Iran ICR Dr Ashraf Mohammadkhani ICR Dr Behbood Sadrolhefazi ICR Dr Morteza Tabatabaeefar ION Ms Farahnaz Kolaei

Iraq ICR Dr Ruqiya Al-Omer Israel ICR Dr Ori Braitbard

ICR Dr Benjamin Klein ICR Dr Dina Raveh YY1 Dr Yinon Ben-Neriah

Italy ACS Dr Alessandra Sala ICR Dr Tiziana Bruno ICR Dr Paolo Conrotto ICR Dr Alessandra di Masi ICR Dr Silvano Gallus ICR Dr Carmen Ghilardi ICR Dr Federica Marchesi ICR Dr Augusto Orlandi ICR Dr Maria Prencipe ICR Dr Antonella Russo ICR Dr Liliana Torosantucci ICR Dr Vincenzo Zappavigna YY2 Dr Anna Gualandris

Japan ACS Dr Shigeki Bamba Jordan ICR Dr Asem Mansour Kenya ION Ms Mary Gitau Korea (South) ICR Dr Kum Jong

ICR Dr Hyok Ri ICR Dr Yong Ri APC Ms Jin-Sook Choi YY1 Dr Byung Kim

Kuwait ICR Dr T. Sethuraman Latvia ICR Dr Arvids Irmejs Lithuania ICR Dr Narimantas Samalavicius Madagascar ICR Dr Nantenaina

Randrianjafisamindrakotroka Malaysia APC Dr Mohamad Nik Mohamed

APC Dr Mei Siew ICR Dr Wan Abdullah ICR Dr Yoke Ching Foo

Mexico ACS Dr Carlos Rosales ICR Dr Tanya Plett Torres

Nepal APC Dr Diwakar Rajkarnikar ICR Dr Rajesh Dudani ICR Dr Harish Neupane ICR Dr Sujata Pradhan ICR Dr Raju Srivastava ICR Dr Bal Thapa ION Ms Phool Bajracharya Gole ION Ms Swosti Shrestha Ulak

Netherlands ICR Dr Roald Van der Laan ICR Dr Pieter van Vlierberghe

Nigeria ICR Dr Godwin Arotiba ICR Dr Mary Umoh Eyo ICR Dr Sani Malami ICR Dr O. Nnodu ICR Dr Millicent Obajimi ICR Dr Victor Oboro ION Ms Habiba Gumel

Norway ICR Dr Salah Ibrahim Peru ICR Dr Juana Hernandez

ICR Dr Luis Pinillos Philippines ICR Dr Ida Marie Lim Poland ICR Dr Karolina Golachowska

ICR Dr Tomasz Graja

ICR Dr Krzysztof Lemke ICR Dr Izabela Mlynarczuk-Bialy ICR Dr Piortr Mrowka ICR Dr Pawel Mroz

Romania ICR Dr Cristian Cojocaru ICR Dr Razvan Socolov YY2 Dr Bogdan Grigoriu

Russia ICR Dr Dmitry Kharazishvili ICR Dr Maria Kustova ICR Dr Alexander Sobolev ICR Dr Alexander Tertychnyy YY2 Dr Alena Maljukova

Serbia and Montenegro ICR Dr Aleksandar Celebic ICR Dr Milica Kontic ICR Dr Borislava Petrovic

Slovakia ICR Dr Frantiska Hruba ICR Dr Erika Kimlickova ICR Dr Juraj Labaj

South Africa ICR Dr Vikash Sewram Spain ICR Dr Ana Sanchez de AbajoSri Lanka ION Dr Sriya Walisundara Sudan ICR Dr Mohamed Ahmed

ICR Dr Abdelbagi Osman Sweden ACS Dr Jonas Fuxe

ACS Dr Xuri Li ICR Dr Lena Claesson-Welsh ICR Dr Anna Ekoff ICR Dr Cecilia Krona

Switzerland YY2 Dr Roland MeierThailand ICR Dr Pongsatorn Supaattagorn Turkey ICR Dr Aysegul Uner Uganda ICRR Dr Edward Katongole-Mbidde Ukraine ICR Dr Ramziya Kyyamova

ICR Dr Natalia Valkovskaya United Kingdom ACS Dr Marcus Munafo

ICR Dr Kim Hawkins Uruguay ICR Dr Henia Balter Binsky

ICR Dr Cynthia de Almeida Esteves ICR Dr Liliana Gladys Suarez Hinojosa

LegendACS American Cancer Society International Fellowship for

Beginning InvestigatorsAPC Asia-Pacific Cancer Society Training GrantICR International Cancer Technology Transfer FellowshipION Trish Greene International Oncology Nursing FellowshipTCR Translational Cancer Research FellowshipYY1 Yamagiwa-Yoshida Memorial International Cancer Study

Grants (April)YY2 Yamagiwa-Yoshida Memorial International Cancer Study

Grants (October)

32 UICC Annual Report 200432 UICC Annual Report 2004

Financial report

The audit of the 2004 accountsof the International Union

Against Cancer was conducted byDeloitte and Touche SA.Theaudited accounts, summarised onp. 35, indicate that UICC endedthe 2004 financial year with adeficit of US$ 148,004 in its unre-stricted accounts. Nevertheless,taking into consideration two pro-visions in the amount of US$ 216,667 made in 2003 forthe WCCO conference in 2004and for two new staff positions,the final balance of its unrestrictedaccounts for 2004 should read apositive balance of US$ 68,663.

We are pleased to note that theUICC policy of diversifying cur-rency exposure by invoicingnational subscriptions and duescontributions in local currencywherever possible continues tohave a stabilising effect.

Income

Total restricted and unrestrictedincome in 2004 amounted to US$ 4,917,810 compared withUS$ 5,797,871 for the precedingyear.This was mainly due to the

fact that restricted funds areaccounted for on a cash basis;sometimes, there may be a timeframe between reception and dis-bursement of funds.

Unrestricted income amountedto US$ 2,066,490, in line with thepreceding year, considering that in2003 the total royalties from theInternational Journal of Cancer(IJC) included the 2002 and 2003amounts due to the renegotiationof the contract. Furthermore, in2003, the publisher of the IJC,John Wiley & Sons, Inc., became acorporate member of UICC.

Membership dues: At its annualmeeting, the Finance Committeecarefully considered the financialsituation of a number of membersand took appropriate action allow-ing longer payment for some ofthem due to political or financialnational instabilities.

Donations: UICC received twosignificant gifts, one from CreditSuisse for the publication of thehandbook on cancer preventionfor NGOs in Europe and onefrom an anonymous donor for

UICC cancer prevention and earlydetection activities.The FinanceCommittee would like to take thisopportunity to express their grati-tude to those donors.

Expenditure

Unrestricted expenditure: InNovember 2004, UICC held its4th World Conference for CancerOrganisations in Dublin, Ireland,preceded by a special generalassembly and business meetings.On this occasion, UICC launchedits revamped logo and corporateimage, reflected in all publications,website and exhibition material.UICC also produced new infor-mation resources (UICC eNews,individual project flyers andposters, a summary of the Dublinplenary sessions that was translatedinto several languages, and a videosummarising key conferenceevents that was shown at the clos-ing ceremony).

Strategic directions: The fol-lowing key activities were sup-ported:

Prevention and early detectionEvidence-based Cancer Prevention:

Strategies for NGOs - A UICC

Handbook for Europe (translatedinto several languages) andaccompanying workshops forcancer society and public healthprofessionalsTobacco controlThe GLOBALink tobacco com-munications network Knowledge transferProfessional education trainingresourcesTNM classification of malignanttumours Fellowships, totalling approxi-mately US$ 1.6 million

Report of the Treasurer and the Chair of the Finance Committee

Dr Louis Jean Denis (Belgium),Treasurer

Mr John C. Baity (USA), Chair,Finance Committee

UIC

C A

nnua

l Rep

ort

2004


UICC International UnionAgainst Cancer

Capacity building: patient sup-portBreast cancer support informa-tion and training resourcesInformation and resourcesPublications, including theInternational Journal of Cancerand the UICC Calendar ofInternational CancerConferences, totalling approxi-mately US$ 1.25 million.

Fund balance

Provisions: As a matter of policy,UICC has built provisions of300,000 Swiss francs towards thecost of the relocation of its officein Geneva. Furthermore, accordingto the instructions given by theExecutive Committee inNovember 2003, the amount ofthe statutory reserve was increasedby US$ 50,000 in 2004.Althoughthe financial situation of theUnion is stable, additional fundswill be needed to carry out strate-gic activities and fund growth inactivities in support of its mission.

On behalf of UICC, we wish toexpress appreciation and gratitudeto those member organisationsthat, in addition to annual duesand national subscriptions, madespecial contributions to UICCactivities in 2004. Our apprecia-tion goes equally to the manyother organisations, corporationsand foundations that contributedgenerously to UICC's activities byproviding local support for UICCworkshops, or hosting conferencesor meetings held in their region.The list of contributors is foundon p.36.

Geneva, 2 June 2005

Tax statusThe International Union Against Cancer (the ‘Union’) is a non-prof-

it, international, non-governmental organisation governed inaccordance with the articles 60 to 79 of the Swiss Civil Code. It isdevoted to the advancement of scientific and medical knowledge inthe research, diagnostics, therapy and prevention of cancer. It pro-motes the campaign against cancer throughout the world.

As a non-profit organisation devoted to the public interest, theUnion has been exempted from income taxes by the Swiss taxauthorities. This exemption is renewable every five years and is duefor renewal in May 2006.

from the Auditors' Report

The International Union Against Cancer (UICC) is devoted exclusive-ly to all aspects of the worldwide fight against cancer. Its objectives

are to advance scientific and medical knowledge in research, diagnosis,treatment and prevention of cancer, and to promote all other aspectsof the campaign against cancer throughout the world. Particularemphasis is placed on professional and public education.

Founded in 1933, UICC is a non-governmental, independent associ-ation of more than 270 member organisations in over 80 countries.Members are voluntary cancer leagues and societies, cancer researchand treatment centres and, in some countries, ministries of health.

UICC is non-profit, non-political and non-sectarian. Its headquartersare in Geneva, Switzerland. It creates and carries out programmesaround the world in collaboration with hundreds of volunteer experts.It works in four strategic directions: prevention and early detection,tobacco control, knowledge transfer, and capacity building. Supportedby membership dues, national subscriptions, grants and donations, itsannual budget is about US$ 5 million.

UICC is governed by its members through a General Assembly,which, beginning in 2006, will meet every two years. Responsibility forprogramme structure and implementation will move from the presentCouncil and Executive Committee to an elected Board of Directors.*

UICC organises a World Cancer Congress (from 2006, every twoyears) as well as annual symposia, workshops and training courses. Itpublishes the International Journal of Cancer (30 issues per year),UICC eNews (every second month), bloom, the newsletter of Reachto Recovery International (twice yearly), a Calendar of InternationalCancer Conferences (twice yearly), and technical reports, textbooks,and manuals.

* See the Joint message from the President and Executive Director (pp.2f.) and Milestones (p.4).

UIC

C A

nnua

l Rep

ort

2004


Balance Sheet as at 31 December 2004 in US Dollars

AssetsUnrestricted:Cash equivalents:

Current accountsTime deposits

Accounts receivable:Membership dues, netRelated partiesOther

Prepaid expensesFixed assets, net

TOTAL

Donor Restricted:Receivable from unrestricted funds

Liabilities and Fund BalancesUnrestricted:Accounts payable and accrued expenses:

Related partiesOther

Due to restricted fundsReserve for blocked currenciesOther liabilitiesTranslation differenceStatutory reserveFund balance

TOTAL

Donor Restricted:Trust funds

2004

479,7972,931,408

23,2115,394

286,53528,57633,236

3,788,157

1,559,032

15,770390,920

1,559,03213,407

900,111(6,361)

150,000765,278

3,788,157

1,559,032

2003

230,5233,397,033

60,9083,412

54,02919,79733,180

3,798,882

1,833,742

40,473173,149

1,833,74211,540

634,21292,484

100,000913,282

3,798,882

1,833,742

Income restricted & unrestricted 2004USD 4,917,810.-

$1,130,91823%

$222,0215%

$2,207,24744%

$1,357,62428% Strategic programme activities

Information and publications

Membership dues

Other

Expenditure restricted & unrestricted 2004 USD 5,340,524.-

$1,259,82424%

$482,5159%

$3,598,18567%

Strategic programme activities

Information and publications

Administration and membership services

The accounts, as presented, have been audited by Deloitte & Touche SA, Geneva, Switzerland. A complete set of the financial statementsfor 2004 may be obtained on request from UICC headquarters in Geneva.


Centers for Disease Control and Prevention, USAAmerican Cancer Society, USANational Cancer Institute, USAJohn Wiley & Sons, Inc.Cancer Research UKJapan National Committee for UICC/Kyowa Hakko Kogyo Company Ltd/Toray Industries IncorporatedNovartis, SwitzerlandRockefeller Foundation, USANational League Against Cancer, FranceEuropean Commission/Quit, UKSwedish Cancer SocietyWorld Health OrganizationJohns Hopkins Bloomberg School of Public Health, USAMobile Manufacturers Forum, BelgiumGSM Association, IrelandInternational Gynecologic Cancer Society, USA American Society for Clinical Oncology, USAOncology Nursing Society, USACanadian Cancer Society/National Cancer Institute, CanadaCancer Council Australia/William Rudder Memorial FundDutch Cancer SocietyDeutsche Krebshilfe/Dr Mildred Scheel Foundation, GermanyItalian Association for Cancer ResearchAssociation of UICC FellowsItalian League Against TumoursDanish Cancer SocietyIsrael Cancer AssociationCancer Society of FinlandPortuguese League Against CancerCentre for Addiction and Mental Health, Canada

Fondation BNP Paribas, SwitzerlandCredit Suisse Group Jubilee Foundation, Switzerland

Anonymous donations

Roll of Honour

RoyaltiesJohn Wiley & Sons, Inc.

Indirect contributorsAstraZeneca Oncology, Global Breast Cancer Foundation, SingaporeCancer Council AustraliaDeloitte, IrelandDepartment of Health and Children,IrelandDeutsches Krebsforschungszentrum,GermanyFáilte Ireland GlaxoSmithKline ConsumerHealthcare, IrelandHealth Promotion Unit, Department ofHealth and Children, Ireland

Health Related InformationDissemination Amongst Youth (HRI-DAY), IndiaIncentive Logic, USAInstitute of Health Information andStatistics of the Czech Republic Instituto Nacional do Cancer (INCA),BrazilIrish Cancer SocietyNational League Against Cancer,FranceNational Lottery, IrelandNicotinaweb, Spain

Novartis, IrelandOncology Nursing Society, USA Pfizer Consumer Healthcare, IrelandRoche Products, IrelandSanofi-aventis Global OncologySanofi-aventis, IrelandSingapore Cancer Society

Contributing suppliersDeloitte & Touche, SwitzerlandGyro Group, SwitzerlandSun Microsystems, Switzerland

AmountUSD

450,907 414,000 332,500 195,000165,068

140,000125,000 100,000 75,799 70,115 45,803 42,000 40,000 36,192 35,626 35,000 30,000 30,000 28,000 26,650 23,677 20,000 18,000 16,83011,689 11,000 7,000 6,066 5,104 5,000

CHF200,00050,000

230,057

USD12,777

505,775

UICC Contributors 2004

UICC is the only international non-governmental organisation dedicated exclusively to the global control of cancer.Its vision is of a world where cancer is eliminated as a major life-threatening disease for future generations.

resource for actionvoice for change

International Union Against Cancer (UICC)3, rue du Conseil Général • 1205 Geneva • SwitzerlandTel.: +41 22 809 18 11 • Fax: +41 22 809 18 10 • email: [email protected] • Website: wwww.uicc.org

Annual Report 2004

Annual Report 2004 - UICCold.uicc.org/templates/uicc/pdf/ar/04.pdf · Arun P. Kurkure (India)...

Documents

Transcript of Annual Report 2004 - UICCold.uicc.org/templates/uicc/pdf/ar/04.pdf · Arun P. Kurkure (India)...